# Salesforce timeline entity: /record/salesforce.md id: ent_salesforce ## undated - undated | cik | 0001108524 | valid | [clm_0DFD4CD8EE2D](/claim/clm_0DFD4CD8EE2D.md) - undated | listed_on | NYSE | valid | [clm_25CCAAE10C5E](/claim/clm_25CCAAE10C5E.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_322E6A1AD197](/claim/clm_322E6A1AD197.md) - undated | ticker | CRM | valid | [clm_350C0978966D](/claim/clm_350C0978966D.md) - undated to 2003-12-18 | registrant_name | Salesforce, Inc. | superseded | [clm_52BD8CBF3F00](/claim/clm_52BD8CBF3F00.md) - undated | fiscal_year_end | 01-31 | valid | [clm_D1384E346291](/claim/clm_D1384E346291.md) - undated | state_of_incorporation | DE | valid | [clm_E4B462BD0092](/claim/clm_E4B462BD0092.md) - undated | subsidiary | ClickSoftware Technologies | unverified | [clm_2E326B2E6F7C](/claim/clm_2E326B2E6F7C.md) - undated | member_of | CVE Numbering Authority | unverified | [clm_333761BC4E3B](/claim/clm_333761BC4E3B.md) - undated | subsidiary | MuleSoft | unverified | [clm_3538F8D0466E](/claim/clm_3538F8D0466E.md) - undated | member_of | Business Software Alliance | unverified | [clm_35A7B5DE7ED2](/claim/clm_35A7B5DE7ED2.md) - undated | subsidiary | Tableau Software, Inc. | unverified | [clm_691557CF28F3](/claim/clm_691557CF28F3.md) - undated | member_of | Open Invention Network | unverified | [clm_711381F2270B](/claim/clm_711381F2270B.md) - undated | member_of | [World Wide Web Consortium](/record/w3c.md) | unverified | [clm_7A2B18F21230](/claim/clm_7A2B18F21230.md) - undated | legal_form | corporation | unverified | [clm_8849DDF0CBF7](/claim/clm_8849DDF0CBF7.md) - undated | country | United States | unverified | [clm_92425DAFEC44](/claim/clm_92425DAFEC44.md) - undated | website | https://www.salesforce.com | unverified | [clm_A7E706BE17B9](/claim/clm_A7E706BE17B9.md) - undated | subsidiary | Heroku | unverified | [clm_D695408768DD](/claim/clm_D695408768DD.md) - undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_DA636BE2A17B](/claim/clm_DA636BE2A17B.md) - undated | subsidiary | Krux | unverified | [clm_E7D73CFF9628](/claim/clm_E7D73CFF9628.md) ## 1999 - 1999-03-01 | ceo | Marc Benioff | unverified | [clm_C6ADC487A8F8](/claim/clm_C6ADC487A8F8.md) ## 2003 - 2003-12-18 to 2019-06-14 | registrant_name | SALESFORCE COM INC | superseded | [clm_711704F85224](/claim/clm_711704F85224.md) ## 2005 - 2005-12-31 to 2006-12-31 | employees | 767 | superseded | [clm_A4BAC48E4000](/claim/clm_A4BAC48E4000.md) ## 2006 - 2006-12-31 to 2007-12-31 | employees | 1,304 | superseded | [clm_85D60F6A7227](/claim/clm_85D60F6A7227.md) ## 2007 - 2007-01-31 to 2008-01-31 | cash_and_equivalents | 86,608,000 United States dollar | superseded | [clm_6C57D09FEA71](/claim/clm_6C57D09FEA71.md) - 2007-02-01 to 2008-01-31 | net_income | 18,356,000 United States dollar | superseded | [clm_78CA5A9E2CD4](/claim/clm_78CA5A9E2CD4.md) - 2007-02-01 to 2008-01-31 | operating_income | 20,309,000 United States dollar | superseded | [clm_8BE32298F078](/claim/clm_8BE32298F078.md) - 2007-02-01 to 2008-01-31 | revenue | 748,700,000 United States dollar | superseded | [clm_E210EAD85C89](/claim/clm_E210EAD85C89.md) - 2007-12-31 to 2008-12-31 | employees | 2,070 | superseded | [clm_6080AEAD49CB](/claim/clm_6080AEAD49CB.md) ## 2008 - 2008-01-31 to 2008-04-30 | cash_and_equivalents | 279,095,000 United States dollar | superseded | [clm_0183BBE1C55B](/claim/clm_0183BBE1C55B.md) - 2008-01-31 to 2008-02-01 | revenue | 748,700,000 United States dollar | superseded | [clm_5DE927FE98F5](/claim/clm_5DE927FE98F5.md) - 2008-01-31 to 2008-02-01 | net_income | 18,356,000 United States dollar | superseded | [clm_9AC53B8F841A](/claim/clm_9AC53B8F841A.md) - 2008-01-31 to 2009-01-31 | research_and_development | 63,812,000 United States dollar | superseded | [clm_9B327730E8A6](/claim/clm_9B327730E8A6.md) - 2008-01-31 to 2008-02-01 | operating_income | 20,309,000 United States dollar | superseded | [clm_EAE8269785D3](/claim/clm_EAE8269785D3.md) - 2008-02-01 to 2009-01-31 | net_income | 43,428,000 United States dollar | superseded | [clm_0281042B5653](/claim/clm_0281042B5653.md) - 2008-02-01 to 2009-01-31 | revenue | 1,076,769,000 United States dollar | superseded | [clm_9BC53033ABFE](/claim/clm_9BC53033ABFE.md) - 2008-02-01 to 2009-01-31 | operating_income | 63,742,000 United States dollar | superseded | [clm_C5770ED22A8F](/claim/clm_C5770ED22A8F.md) - 2008-04-30 to 2008-07-31 | cash_and_equivalents | 378,548,000 United States dollar | superseded | [clm_E44C753BCFE8](/claim/clm_E44C753BCFE8.md) - 2008-07-31 to 2008-10-31 | cash_and_equivalents | 427,043,000 United States dollar | superseded | [clm_43F6F1FFF2AD](/claim/clm_43F6F1FFF2AD.md) - 2008-07-31 to 2008-10-31 | quarterly_revenue | 263,077,000 United States dollar | superseded | [clm_491A93555098](/claim/clm_491A93555098.md) - 2008-07-31 to 2008-10-31 | quarterly_research_and_development | 24,033,000 United States dollar | superseded | [clm_7AF05B14D499](/claim/clm_7AF05B14D499.md) - 2008-07-31 to 2008-10-31 | quarterly_net_income | 9,996,000 United States dollar | superseded | [clm_DBF37577F55B](/claim/clm_DBF37577F55B.md) - 2008-07-31 to 2008-10-31 | quarterly_operating_income | 16,098,000 United States dollar | superseded | [clm_F712259912D7](/claim/clm_F712259912D7.md) - 2008-10-31 to 2009-01-31 | cash_and_equivalents | 382,314,000 United States dollar | superseded | [clm_2749CED5BB99](/claim/clm_2749CED5BB99.md) - 2008-10-31 to 2009-04-30 | quarterly_net_income | 10,124,000 United States dollar | superseded | [clm_35FCC57498BF](/claim/clm_35FCC57498BF.md) - 2008-10-31 to 2009-04-30 | quarterly_operating_income | 16,133,000 United States dollar | superseded | [clm_492E77518A33](/claim/clm_492E77518A33.md) - 2008-10-31 to 2009-04-30 | quarterly_research_and_development | 26,270,000 United States dollar | superseded | [clm_793EDA2A88FC](/claim/clm_793EDA2A88FC.md) - 2008-10-31 to 2009-04-30 | quarterly_revenue | 276,487,000 United States dollar | superseded | [clm_B9AA46B4C9D4](/claim/clm_B9AA46B4C9D4.md) - 2008-12-31 to 2009-12-31 | employees | 2,606 | superseded | [clm_730BFB0D8391](/claim/clm_730BFB0D8391.md) ## 2009 - 2009-01-31 to 2009-02-01 | revenue | 1,076,769,000 United States dollar | superseded | [clm_2E9F8F207DD7](/claim/clm_2E9F8F207DD7.md) - 2009-01-31 to 2009-07-31 | total_equity | 671,784,000 United States dollar | superseded | [clm_35057842B366](/claim/clm_35057842B366.md) - 2009-01-31 to 2009-04-30 | cash_and_equivalents | 483,834,000 United States dollar | superseded | [clm_6343FBDA59BC](/claim/clm_6343FBDA59BC.md) - 2009-01-31 to 2009-02-01 | net_income | 43,428,000 United States dollar | superseded | [clm_72FFCEE0A8E0](/claim/clm_72FFCEE0A8E0.md) - 2009-01-31 to 2010-01-31 | research_and_development | 99,530,000 United States dollar | superseded | [clm_8E98057BC9C2](/claim/clm_8E98057BC9C2.md) - 2009-01-31 to 2009-02-01 | operating_income | 63,742,000 United States dollar | superseded | [clm_A1B60EBE4FB7](/claim/clm_A1B60EBE4FB7.md) - 2009-01-31 to 2009-07-31 | total_assets | 1,479,822,000 United States dollar | superseded | [clm_B4CBEA3A3EF0](/claim/clm_B4CBEA3A3EF0.md) - 2009-02-01 to 2010-01-31 | net_income | 80,719,000 United States dollar | superseded | [clm_46EF04B972EE](/claim/clm_46EF04B972EE.md) - 2009-02-01 to 2010-01-31 | revenue | 1,305,583,000 United States dollar | superseded | [clm_870C3E51DFFE](/claim/clm_870C3E51DFFE.md) - 2009-02-01 to 2010-01-31 | operating_income | 115,272,000 United States dollar | superseded | [clm_871DFC0E0707](/claim/clm_871DFC0E0707.md) - 2009-04-20 | x_username | salesforce | unverified | [clm_159A2E133EB0](/claim/clm_159A2E133EB0.md) - 2009-04-30 to 2009-07-31 | cash_and_equivalents | 341,705,000 United States dollar | superseded | [clm_376C58F62F40](/claim/clm_376C58F62F40.md) - 2009-04-30 to 2009-07-31 | quarterly_research_and_development | 31,584,000 United States dollar | superseded | [clm_5B0D0109C9AB](/claim/clm_5B0D0109C9AB.md) - 2009-04-30 to 2009-07-31 | quarterly_net_income | 18,436,000 United States dollar | superseded | [clm_67C0293A9AFC](/claim/clm_67C0293A9AFC.md) - 2009-04-30 to 2009-07-31 | quarterly_revenue | 304,924,000 United States dollar | superseded | [clm_AE8F2C155ADB](/claim/clm_AE8F2C155ADB.md) - 2009-04-30 to 2009-07-31 | quarterly_operating_income | 30,123,000 United States dollar | superseded | [clm_F8D7E5C0729C](/claim/clm_F8D7E5C0729C.md) - 2009-05-01 | x_username | SalesforceOrg | unverified | [clm_A515B6B01DEF](/claim/clm_A515B6B01DEF.md) - 2009-07-31 to 2009-10-31 | quarterly_operating_income | 29,489,000 United States dollar | superseded | [clm_4C78C41BD0DC](/claim/clm_4C78C41BD0DC.md) - 2009-07-31 to 2009-10-31 | quarterly_research_and_development | 31,103,000 United States dollar | superseded | [clm_6BC712A4EB34](/claim/clm_6BC712A4EB34.md) - 2009-07-31 to 2009-10-31 | cash_and_equivalents | 246,169,000 United States dollar | superseded | [clm_8429E49A2E6D](/claim/clm_8429E49A2E6D.md) - 2009-07-31 to 2009-10-31 | total_assets | 1,556,527,000 United States dollar | superseded | [clm_8CA0A6F7389B](/claim/clm_8CA0A6F7389B.md) - 2009-07-31 to 2009-10-31 | quarterly_revenue | 316,061,000 United States dollar | superseded | [clm_9637007EB45B](/claim/clm_9637007EB45B.md) - 2009-07-31 to 2009-10-31 | quarterly_net_income | 21,198,000 United States dollar | superseded | [clm_A4643596C381](/claim/clm_A4643596C381.md) - 2009-07-31 to 2009-10-31 | total_equity | 791,117,000 United States dollar | superseded | [clm_A8589E51F58B](/claim/clm_A8589E51F58B.md) - 2009-07-31 to 2009-10-31 | shares_outstanding | 124,000,000 shares | superseded | [clm_D5EEA30CFA07](/claim/clm_D5EEA30CFA07.md) - 2009-10-31 to 2010-01-31 | cash_and_equivalents | 242,888,000 United States dollar | superseded | [clm_0742389D4D42](/claim/clm_0742389D4D42.md) - 2009-10-31 to 2010-01-31 | total_equity | 858,891,000 United States dollar | superseded | [clm_4C032006259B](/claim/clm_4C032006259B.md) - 2009-10-31 to 2010-04-30 | quarterly_net_income | 20,691,000 United States dollar | superseded | [clm_53207A87E273](/claim/clm_53207A87E273.md) - 2009-10-31 to 2010-01-31 | total_assets | 1,643,201,000 United States dollar | superseded | [clm_6175AD9AB95A](/claim/clm_6175AD9AB95A.md) - 2009-10-31 to 2010-04-30 | quarterly_operating_income | 30,141,000 United States dollar | superseded | [clm_AC7F2FB3C916](/claim/clm_AC7F2FB3C916.md) - 2009-10-31 to 2010-04-30 | quarterly_revenue | 330,549,000 United States dollar | superseded | [clm_C8FD2B01FBB6](/claim/clm_C8FD2B01FBB6.md) - 2009-10-31 to 2010-04-30 | quarterly_research_and_development | 32,763,000 United States dollar | superseded | [clm_DF7C6A0B9C08](/claim/clm_DF7C6A0B9C08.md) - 2009-10-31 to 2010-01-31 | shares_outstanding | 124,900,000 shares | superseded | [clm_FE3F6806D3B0](/claim/clm_FE3F6806D3B0.md) - 2009-12-31 to 2010-12-31 | employees | 3,566 | superseded | [clm_70220EE6EC95](/claim/clm_70220EE6EC95.md) ## 2010 - 2010-01-31 to 2010-02-01 | net_income | 80,719,000 United States dollar | superseded | [clm_113C92270261](/claim/clm_113C92270261.md) - 2010-01-31 to 2010-04-30 | total_equity | 1,043,802,000 United States dollar | superseded | [clm_1E59D1ED3B92](/claim/clm_1E59D1ED3B92.md) - 2010-01-31 to 2010-04-30 | cash_and_equivalents | 1,011,306,000 United States dollar | superseded | [clm_6B38DF7D9637](/claim/clm_6B38DF7D9637.md) - 2010-01-31 to 2010-02-01 | revenue | 1,305,583,000 United States dollar | superseded | [clm_AF6EBFCF464E](/claim/clm_AF6EBFCF464E.md) - 2010-01-31 to 2010-04-30 | shares_outstanding | 127,200,000 shares | superseded | [clm_B416A3D6BA39](/claim/clm_B416A3D6BA39.md) - 2010-01-31 to 2011-01-31 | research_and_development | 131,897,000 United States dollar | superseded | [clm_C471ED1E2588](/claim/clm_C471ED1E2588.md) - 2010-01-31 to 2010-04-30 | total_assets | 2,460,201,000 United States dollar | superseded | [clm_D95A2D3F3546](/claim/clm_D95A2D3F3546.md) - 2010-01-31 to 2010-02-01 | operating_income | 115,272,000 United States dollar | superseded | [clm_EEB0AD1989B6](/claim/clm_EEB0AD1989B6.md) - 2010-02-01 to 2011-01-31 | net_income | 64,474,000 United States dollar | superseded | [clm_211B59CEB82D](/claim/clm_211B59CEB82D.md) - 2010-02-01 to 2011-01-31 | revenue | 1,657,139,000 United States dollar | superseded | [clm_27290085163C](/claim/clm_27290085163C.md) - 2010-02-01 to 2011-01-31 | operating_income | 97,497,000 United States dollar | superseded | [clm_BB9C62D7FB7F](/claim/clm_BB9C62D7FB7F.md) - 2010-04-30 to 2010-07-31 | quarterly_net_income | 17,745,000 United States dollar | superseded | [clm_144A43BB6AD2](/claim/clm_144A43BB6AD2.md) - 2010-04-30 to 2010-07-31 | quarterly_operating_income | 33,050,000 United States dollar | superseded | [clm_15A4416F0C4D](/claim/clm_15A4416F0C4D.md) - 2010-04-30 to 2010-07-31 | shares_outstanding | 128,700,000 shares | superseded | [clm_1C2ED7996234](/claim/clm_1C2ED7996234.md) - 2010-04-30 to 2010-07-31 | total_assets | 2,488,097,000 United States dollar | superseded | [clm_575D5FF9B212](/claim/clm_575D5FF9B212.md) - 2010-04-30 to 2010-07-31 | cash_and_equivalents | 690,794,000 United States dollar | superseded | [clm_8BCD29F668B9](/claim/clm_8BCD29F668B9.md) - 2010-04-30 to 2010-07-31 | total_equity | 1,134,510,000 United States dollar | superseded | [clm_9D84663F197C](/claim/clm_9D84663F197C.md) - 2010-04-30 to 2010-07-31 | quarterly_research_and_development | 40,122,000 United States dollar | superseded | [clm_BDB71263CA76](/claim/clm_BDB71263CA76.md) - 2010-04-30 to 2010-07-31 | quarterly_revenue | 376,813,000 United States dollar | superseded | [clm_D0E13054B432](/claim/clm_D0E13054B432.md) - 2010-07-31 to 2010-10-31 | quarterly_operating_income | 29,682,000 United States dollar | superseded | [clm_34742312F104](/claim/clm_34742312F104.md) - 2010-07-31 to 2010-10-31 | total_equity | 1,240,626,000 United States dollar | superseded | [clm_3C18BA7D7E3B](/claim/clm_3C18BA7D7E3B.md) - 2010-07-31 to 2010-10-31 | quarterly_net_income | 14,744,000 United States dollar | superseded | [clm_3F7AE36313C3](/claim/clm_3F7AE36313C3.md) - 2010-07-31 to 2010-10-31 | total_assets | 2,698,476,000 United States dollar | superseded | [clm_4F012ABD5734](/claim/clm_4F012ABD5734.md) - 2010-07-31 to 2010-10-31 | shares_outstanding | 129,900,000 shares | superseded | [clm_5E42ADEAD371](/claim/clm_5E42ADEAD371.md) - 2010-07-31 to 2010-10-31 | quarterly_research_and_development | 42,930,000 United States dollar | superseded | [clm_5FDBE24FA552](/claim/clm_5FDBE24FA552.md) - 2010-07-31 to 2010-10-31 | cash_and_equivalents | 409,925,000 United States dollar | superseded | [clm_6D90EBB75D8C](/claim/clm_6D90EBB75D8C.md) - 2010-07-31 to 2010-10-31 | quarterly_revenue | 394,372,000 United States dollar | superseded | [clm_DA50CEB01655](/claim/clm_DA50CEB01655.md) - 2010-10-31 to 2011-04-30 | quarterly_research_and_development | 47,305,000 United States dollar | superseded | [clm_2F8B9025DD1A](/claim/clm_2F8B9025DD1A.md) - 2010-10-31 to 2011-01-31 | shares_outstanding | 131,400,000 shares | superseded | [clm_409191DC6DA2](/claim/clm_409191DC6DA2.md) - 2010-10-31 to 2011-04-30 | quarterly_operating_income | 35,156,000 United States dollar | superseded | [clm_52025DAA7692](/claim/clm_52025DAA7692.md) - 2010-10-31 to 2011-01-31 | cash_and_equivalents | 630,303,000 United States dollar | superseded | [clm_548662DA4A9D](/claim/clm_548662DA4A9D.md) - 2010-10-31 to 2011-01-31 | total_assets | 2,740,694,000 United States dollar | superseded | [clm_95B1721A3430](/claim/clm_95B1721A3430.md) - 2010-10-31 to 2011-04-30 | quarterly_net_income | 21,072,000 United States dollar | superseded | [clm_9CAE04C73242](/claim/clm_9CAE04C73242.md) - 2010-10-31 to 2011-04-30 | quarterly_revenue | 429,087,000 United States dollar | superseded | [clm_BBF80F78DDDD](/claim/clm_BBF80F78DDDD.md) - 2010-10-31 to 2011-01-31 | total_equity | 1,210,288,000 United States dollar | superseded | [clm_FD653E9FA95A](/claim/clm_FD653E9FA95A.md) - 2010-12-31 to 2011-12-31 | employees | 3,969 | superseded | [clm_6D4002D984AC](/claim/clm_6D4002D984AC.md) ## 2011 - 2011-01-31 to 2011-04-30 | total_assets | 3,091,165,000 United States dollar | superseded | [clm_1F8F08AF3B70](/claim/clm_1F8F08AF3B70.md) - 2011-01-31 to 2011-02-01 | revenue | 1,657,139,000 United States dollar | superseded | [clm_7807267E8567](/claim/clm_7807267E8567.md) - 2011-01-31 to 2011-04-30 | total_equity | 1,276,491,000 United States dollar | superseded | [clm_7F28E856431C](/claim/clm_7F28E856431C.md) - 2011-01-31 to 2011-04-30 | shares_outstanding | 132,900,000 shares | superseded | [clm_80353619F167](/claim/clm_80353619F167.md) - 2011-01-31 to 2011-02-01 | operating_income | 97,497,000 United States dollar | superseded | [clm_A256FB9C1F78](/claim/clm_A256FB9C1F78.md) - 2011-01-31 to 2012-01-31 | research_and_development | 187,887,000 United States dollar | superseded | [clm_AE92F4285C69](/claim/clm_AE92F4285C69.md) - 2011-01-31 to 2011-04-30 | cash_and_equivalents | 424,292,000 United States dollar | superseded | [clm_E6AAF0BEAC66](/claim/clm_E6AAF0BEAC66.md) - 2011-01-31 to 2011-02-01 | net_income | 64,474,000 United States dollar | superseded | [clm_ECDAAB84B365](/claim/clm_ECDAAB84B365.md) - 2011-02-01 to 2012-01-31 | net_income | -11,572,000 United States dollar | superseded | [clm_8451A2C29057](/claim/clm_8451A2C29057.md) - 2011-02-01 to 2012-01-31 | revenue | 2,266,539,000 United States dollar | superseded | [clm_9E04780E8C20](/claim/clm_9E04780E8C20.md) - 2011-02-01 to 2012-01-31 | operating_income | -35,085,000 United States dollar | superseded | [clm_D136B30F4839](/claim/clm_D136B30F4839.md) - 2011-04-30 to 2011-07-31 | total_equity | 1,255,642,000 United States dollar | superseded | [clm_2C1FEA57875A](/claim/clm_2C1FEA57875A.md) - 2011-04-30 to 2011-07-31 | total_assets | 3,128,068,000 United States dollar | superseded | [clm_4679693C2B6C](/claim/clm_4679693C2B6C.md) - 2011-04-30 to 2011-07-31 | shares_outstanding | 133.90 shares | superseded | [clm_576A57DD4B5A](/claim/clm_576A57DD4B5A.md) - 2011-04-30 to 2011-07-31 | quarterly_net_income | 530,000 United States dollar | superseded | [clm_585A2104A1D2](/claim/clm_585A2104A1D2.md) - 2011-04-30 to 2011-07-31 | quarterly_revenue | 504,364,000 United States dollar | superseded | [clm_A7CC7841EC0A](/claim/clm_A7CC7841EC0A.md) - 2011-04-30 to 2011-07-31 | cash_and_equivalents | 664,612,000 United States dollar | superseded | [clm_BCA28AC55613](/claim/clm_BCA28AC55613.md) - 2011-04-30 to 2011-07-31 | quarterly_operating_income | -2,803,000 United States dollar | superseded | [clm_CB21DBEF6DF1](/claim/clm_CB21DBEF6DF1.md) - 2011-04-30 to 2011-07-31 | quarterly_research_and_development | 65,292,000 United States dollar | superseded | [clm_CB34E8E68D62](/claim/clm_CB34E8E68D62.md) - 2011-07-31 to 2011-10-31 | quarterly_operating_income | -15,748,000 United States dollar | superseded | [clm_14D5805ABA1E](/claim/clm_14D5805ABA1E.md) - 2011-07-31 to 2011-10-31 | quarterly_net_income | -4,268,000 United States dollar | superseded | [clm_365657FE81DE](/claim/clm_365657FE81DE.md) - 2011-07-31 to 2011-10-31 | cash_and_equivalents | 449,794,000 United States dollar | superseded | [clm_74675A2E8014](/claim/clm_74675A2E8014.md) - 2011-07-31 to 2011-10-31 | total_equity | 1,418,123,000 United States dollar | superseded | [clm_98BF4CFC2B86](/claim/clm_98BF4CFC2B86.md) - 2011-07-31 to 2011-10-31 | shares_outstanding | 135,500,000 shares | superseded | [clm_D7C92835B85B](/claim/clm_D7C92835B85B.md) - 2011-07-31 to 2011-10-31 | quarterly_research_and_development | 73,393,000 United States dollar | superseded | [clm_DA33B62DE410](/claim/clm_DA33B62DE410.md) - 2011-07-31 to 2011-10-31 | quarterly_revenue | 546,002,000 United States dollar | superseded | [clm_DA679652DB11](/claim/clm_DA679652DB11.md) - 2011-07-31 to 2011-10-31 | total_assets | 3,421,328,000 United States dollar | superseded | [clm_F9BF08882D95](/claim/clm_F9BF08882D95.md) - 2011-10-31 to 2012-01-31 | shares_outstanding | 136,000,000 shares | superseded | [clm_0AE3A389C98D](/claim/clm_0AE3A389C98D.md) - 2011-10-31 to 2012-01-31 | total_equity | 1,498,389,000 United States dollar | superseded | [clm_0B18AD27ED82](/claim/clm_0B18AD27ED82.md) - 2011-10-31 to 2012-04-30 | quarterly_revenue | 584,260,000 United States dollar | superseded | [clm_19F5F7A437AA](/claim/clm_19F5F7A437AA.md) - 2011-10-31 to 2012-01-31 | cash_and_equivalents | 502,987,000 United States dollar | superseded | [clm_35D51F8295D0](/claim/clm_35D51F8295D0.md) - 2011-10-31 to 2012-04-30 | quarterly_operating_income | -10,157,000 United States dollar | superseded | [clm_665E44C53662](/claim/clm_665E44C53662.md) - 2011-10-31 to 2012-01-31 | total_assets | 3,511,278,000 United States dollar | superseded | [clm_8C9E47D1952F](/claim/clm_8C9E47D1952F.md) - 2011-10-31 to 2012-04-30 | quarterly_research_and_development | 76,049,000 United States dollar | superseded | [clm_93009DF0AC40](/claim/clm_93009DF0AC40.md) - 2011-10-31 to 2012-04-30 | quarterly_net_income | -3,756,000 United States dollar | superseded | [clm_EA4318E46FC7](/claim/clm_EA4318E46FC7.md) - 2011-12-31 to 2012-12-31 | employees | 5,306 | superseded | [clm_5DE289A10CCC](/claim/clm_5DE289A10CCC.md) ## 2012 - 2012-01-31 to 2012-04-30 | total_assets | 4,164,154,000 United States dollar | superseded | [clm_1AD1631B3FCE](/claim/clm_1AD1631B3FCE.md) - 2012-01-31 to 2012-02-01 | operating_income | -35,085,000 United States dollar | superseded | [clm_4DCB436F636A](/claim/clm_4DCB436F636A.md) - 2012-01-31 to 2012-04-30 | cash_and_equivalents | 607,284,000 United States dollar | superseded | [clm_6DB5F3061F5F](/claim/clm_6DB5F3061F5F.md) - 2012-01-31 to 2012-02-01 | revenue | 2,266,539,000 United States dollar | superseded | [clm_C745237B4677](/claim/clm_C745237B4677.md) - 2012-01-31 to 2012-02-01 | net_income | -11,572,000 United States dollar | superseded | [clm_D10EB360875F](/claim/clm_D10EB360875F.md) - 2012-01-31 to 2013-01-31 | research_and_development | 295,347,000 United States dollar | superseded | [clm_DB37012DB155](/claim/clm_DB37012DB155.md) - 2012-01-31 to 2012-04-30 | shares_outstanding | 137,000,000 shares | superseded | [clm_DB91F7E5445F](/claim/clm_DB91F7E5445F.md) - 2012-01-31 to 2012-04-30 | total_equity | 1,587,360,000 United States dollar | superseded | [clm_EF950703FB4E](/claim/clm_EF950703FB4E.md) - 2012-02-01 to 2013-01-31 | net_income | -270,445,000 United States dollar | superseded | [clm_1483D2E59390](/claim/clm_1483D2E59390.md) - 2012-02-01 to 2013-01-31 | revenue | 3,050,195,000 United States dollar | superseded | [clm_45F79ADA023A](/claim/clm_45F79ADA023A.md) - 2012-02-01 to 2013-01-31 | operating_income | -110,710,000 United States dollar | superseded | [clm_F5D330782343](/claim/clm_F5D330782343.md) - 2012-02-09 | x_username | SalesforceEng | unverified | [clm_6A8E4600D8CA](/claim/clm_6A8E4600D8CA.md) - 2012-04-30 to 2012-07-31 | total_assets | 4,156,092,000 United States dollar | superseded | [clm_2275B409D805](/claim/clm_2275B409D805.md) - 2012-04-30 to 2012-07-31 | total_equity | 1,809,769,000 United States dollar | superseded | [clm_4B208B406755](/claim/clm_4B208B406755.md) - 2012-04-30 to 2012-07-31 | quarterly_operating_income | -22,249,000 United States dollar | superseded | [clm_5781434F5B4D](/claim/clm_5781434F5B4D.md) - 2012-04-30 to 2012-07-31 | quarterly_net_income | -19,475,000 United States dollar | superseded | [clm_6A5597265F55](/claim/clm_6A5597265F55.md) - 2012-04-30 to 2012-07-31 | quarterly_revenue | 695,467,000 United States dollar | superseded | [clm_8784E2EF5D4B](/claim/clm_8784E2EF5D4B.md) - 2012-04-30 to 2012-07-31 | cash_and_equivalents | 440,785,000 United States dollar | superseded | [clm_8B549DE12FC4](/claim/clm_8B549DE12FC4.md) - 2012-04-30 to 2012-07-31 | quarterly_research_and_development | 94,776,000 United States dollar | superseded | [clm_B55CAFCD7D57](/claim/clm_B55CAFCD7D57.md) - 2012-04-30 to 2012-07-31 | shares_outstanding | 138,000,000 shares | superseded | [clm_F3A9368BF3F3](/claim/clm_F3A9368BF3F3.md) - 2012-07-31 to 2012-10-31 | shares_outstanding | 139,000,000 shares | superseded | [clm_07DD2A975122](/claim/clm_07DD2A975122.md) - 2012-07-31 to 2012-08-13 | cash_and_equivalents | 1,000,730,000 United States dollar | superseded | [clm_4C07ACA7B9E8](/claim/clm_4C07ACA7B9E8.md) - 2012-07-31 to 2012-10-31 | quarterly_net_income | -9,829,000 United States dollar | superseded | [clm_5B23D0F6FD8C](/claim/clm_5B23D0F6FD8C.md) - 2012-07-31 to 2012-10-31 | total_assets | 4,453,570,000 United States dollar | superseded | [clm_6726D76728EC](/claim/clm_6726D76728EC.md) - 2012-07-31 to 2012-10-31 | quarterly_operating_income | -13,466,000 United States dollar | superseded | [clm_896071002E28](/claim/clm_896071002E28.md) - 2012-07-31 to 2012-10-31 | total_equity | 1,892,314,000 United States dollar | superseded | [clm_A868A4FA29FC](/claim/clm_A868A4FA29FC.md) - 2012-07-31 to 2012-10-31 | quarterly_revenue | 731,649,000 United States dollar | superseded | [clm_D2D6FAD55BED](/claim/clm_D2D6FAD55BED.md) - 2012-07-31 to 2012-10-31 | quarterly_research_and_development | 99,442,000 United States dollar | superseded | [clm_F72D5D563AB6](/claim/clm_F72D5D563AB6.md) - 2012-08-13 to 2012-10-31 | cash_and_equivalents | 1,000,730,000 United States dollar | superseded | [clm_5286A36BE220](/claim/clm_5286A36BE220.md) - 2012-10-31 to 2013-04-30 | quarterly_operating_income | -54,188,000 United States dollar | superseded | [clm_13449E0F7573](/claim/clm_13449E0F7573.md) - 2012-10-31 to 2013-01-31 | total_assets | 4,642,290,000 United States dollar | superseded | [clm_54A373D15D1E](/claim/clm_54A373D15D1E.md) - 2012-10-31 to 2013-04-30 | quarterly_revenue | 788,398,000 United States dollar | superseded | [clm_70D09D4693DB](/claim/clm_70D09D4693DB.md) - 2012-10-31 to 2013-01-31 | shares_outstanding | 142,000,000 shares | superseded | [clm_75E1B1645DEA](/claim/clm_75E1B1645DEA.md) - 2012-10-31 to 2013-01-31 | cash_and_equivalents | 521,720,000 United States dollar | superseded | [clm_9AA5E64E2040](/claim/clm_9AA5E64E2040.md) - 2012-10-31 to 2013-04-30 | quarterly_net_income | -220,297,000 United States dollar | superseded | [clm_A01E74E7F035](/claim/clm_A01E74E7F035.md) - 2012-10-31 to 2013-04-30 | quarterly_research_and_development | 114,074,000 United States dollar | superseded | [clm_AADDF2A2721F](/claim/clm_AADDF2A2721F.md) - 2012-10-31 to 2013-01-31 | total_equity | 2,083,615,000 United States dollar | superseded | [clm_BE80129348E6](/claim/clm_BE80129348E6.md) - 2012-12-31 to 2013-12-31 | employees | 7,785 | superseded | [clm_828158A6C9AC](/claim/clm_828158A6C9AC.md) ## 2013 - 2013-01-31 to 2013-04-30 | shares_outstanding | 146,400,000 shares | superseded | [clm_4526DFCAC0E4](/claim/clm_4526DFCAC0E4.md) - 2013-01-31 to 2014-01-31 | research_and_development | 429,479,000 United States dollar | superseded | [clm_54020B50A0BB](/claim/clm_54020B50A0BB.md) - 2013-01-31 to 2013-02-01 | net_income | -270,445,000 United States dollar | superseded | [clm_68E6F52A51A2](/claim/clm_68E6F52A51A2.md) - 2013-01-31 to 2013-02-01 | revenue | 3,050,195,000 United States dollar | superseded | [clm_801DEAC748F5](/claim/clm_801DEAC748F5.md) - 2013-01-31 to 2013-04-30 | cash_and_equivalents | 747,245,000 United States dollar | superseded | [clm_9075BFD57B1E](/claim/clm_9075BFD57B1E.md) - 2013-01-31 to 2013-04-30 | total_equity | 2,317,633,000 United States dollar | superseded | [clm_C55DF3AB1B31](/claim/clm_C55DF3AB1B31.md) - 2013-01-31 to 2013-02-01 | operating_income | -110,710,000 United States dollar | superseded | [clm_CD2ED655A6AF](/claim/clm_CD2ED655A6AF.md) - 2013-01-31 to 2013-04-30 | total_assets | 5,528,956,000 United States dollar | superseded | [clm_F595CDCFC553](/claim/clm_F595CDCFC553.md) - 2013-02-01 to 2014-01-31 | net_income | -232,175,000 United States dollar | superseded | [clm_089CFFE288F9](/claim/clm_089CFFE288F9.md) - 2013-02-01 to 2014-01-31 | revenue | 4,071,003,000 United States dollar | superseded | [clm_3E1E8EAE46D6](/claim/clm_3E1E8EAE46D6.md) - 2013-02-01 to 2014-01-31 | operating_income | -286,074,000 United States dollar | superseded | [clm_C5CB031FD091](/claim/clm_C5CB031FD091.md) - 2013-04-30 to 2013-07-31 | quarterly_research_and_development | 131,939,000 United States dollar | superseded | [clm_09BC9C8B0E4A](/claim/clm_09BC9C8B0E4A.md) - 2013-04-30 to 2013-07-31 | total_assets | 6,513,709,000 United States dollar | superseded | [clm_0A9D0BF373A0](/claim/clm_0A9D0BF373A0.md) - 2013-04-30 to 2013-07-31 | shares_outstanding | 590,000,000 shares | superseded | [clm_2202889FFD37](/claim/clm_2202889FFD37.md) - 2013-04-30 to 2013-07-31 | quarterly_revenue | 892,633,000 United States dollar | superseded | [clm_592BC3DF2E57](/claim/clm_592BC3DF2E57.md) - 2013-04-30 to 2013-07-31 | quarterly_operating_income | -44,540,000 United States dollar | superseded | [clm_7CD94BC9C77F](/claim/clm_7CD94BC9C77F.md) - 2013-04-30 to 2013-07-31 | cash_and_equivalents | 1,927,990,000 United States dollar | superseded | [clm_83C5451CB4C5](/claim/clm_83C5451CB4C5.md) - 2013-04-30 to 2013-07-31 | total_equity | 2,462,796,000 United States dollar | superseded | [clm_B4D040379423](/claim/clm_B4D040379423.md) - 2013-04-30 to 2013-07-31 | quarterly_net_income | -67,721,000 United States dollar | superseded | [clm_C91A1482E0D1](/claim/clm_C91A1482E0D1.md) - 2013-07-31 to 2013-10-31 | quarterly_operating_income | -39,857,000 United States dollar | superseded | [clm_0829D737F832](/claim/clm_0829D737F832.md) - 2013-07-31 to 2013-10-31 | total_equity | 2,818,649,000 United States dollar | superseded | [clm_2E5FF80F48B6](/claim/clm_2E5FF80F48B6.md) - 2013-07-31 to 2013-10-31 | cash_and_equivalents | 579,881,000 United States dollar | superseded | [clm_3B0E48BA73EF](/claim/clm_3B0E48BA73EF.md) - 2013-07-31 to 2013-10-31 | total_assets | 7,969,896,000 United States dollar | superseded | [clm_4286DC857A74](/claim/clm_4286DC857A74.md) - 2013-07-31 to 2013-10-31 | quarterly_revenue | 957,094,000 United States dollar | superseded | [clm_6DC69F464E30](/claim/clm_6DC69F464E30.md) - 2013-07-31 to 2013-10-31 | quarterly_research_and_development | 148,079,000 United States dollar | superseded | [clm_8ABB581945FC](/claim/clm_8ABB581945FC.md) - 2013-07-31 to 2013-10-31 | shares_outstanding | 596,000,000 shares | superseded | [clm_8BA02C51107F](/claim/clm_8BA02C51107F.md) - 2013-07-31 to 2013-10-31 | quarterly_net_income | 76,603,000 United States dollar | superseded | [clm_C2A3D7217132](/claim/clm_C2A3D7217132.md) - 2013-10-31 to 2014-04-30 | quarterly_revenue | 1,076,034,000 United States dollar | superseded | [clm_30C500EC8960](/claim/clm_30C500EC8960.md) - 2013-10-31 to 2014-01-31 | cash_and_equivalents | 651,750,000 United States dollar | superseded | [clm_38A90F61C4BB](/claim/clm_38A90F61C4BB.md) - 2013-10-31 to 2014-01-31 | total_equity | 2,912,356,000 United States dollar | superseded | [clm_79E04E52B979](/claim/clm_79E04E52B979.md) - 2013-10-31 to 2014-01-31 | shares_outstanding | 603,000,000 shares | superseded | [clm_95B42F3D9876](/claim/clm_95B42F3D9876.md) - 2013-10-31 to 2014-01-31 | total_assets | 8,097,634,000 United States dollar | superseded | [clm_B3626048A113](/claim/clm_B3626048A113.md) - 2013-10-31 to 2014-04-30 | quarterly_operating_income | -97,931,000 United States dollar | superseded | [clm_EB7FB6B93D74](/claim/clm_EB7FB6B93D74.md) - 2013-10-31 to 2014-04-30 | quarterly_research_and_development | 170,690,000 United States dollar | superseded | [clm_FA6C57525B6F](/claim/clm_FA6C57525B6F.md) - 2013-10-31 to 2014-04-30 | quarterly_net_income | -124,434,000 United States dollar | superseded | [clm_FC93D2D1F1E6](/claim/clm_FC93D2D1F1E6.md) - 2013-12-31 to 2014-12-31 | employees | 9,800 | superseded | [clm_637FEC8447B4](/claim/clm_637FEC8447B4.md) ## 2014 - 2014-01-31 to 2014-04-30 | shares_outstanding | 610,100,000 shares | superseded | [clm_26183B8E3C50](/claim/clm_26183B8E3C50.md) - 2014-01-31 to 2014-02-01 | revenue | 4,071,003,000 United States dollar | superseded | [clm_58D845AB90D4](/claim/clm_58D845AB90D4.md) - 2014-01-31 to 2014-02-01 | operating_income | -286,074,000 United States dollar | superseded | [clm_7590D6B06C89](/claim/clm_7590D6B06C89.md) - 2014-01-31 to 2014-02-01 | net_income | -232,175,000 United States dollar | superseded | [clm_8316A2A6C0F9](/claim/clm_8316A2A6C0F9.md) - 2014-01-31 to 2014-04-30 | total_assets | 9,152,930,000 United States dollar | superseded | [clm_88C0303908D0](/claim/clm_88C0303908D0.md) - 2014-01-31 to 2015-01-31 | research_and_development | 623,798,000 United States dollar | superseded | [clm_8E02CE7A1EA0](/claim/clm_8E02CE7A1EA0.md) - 2014-01-31 to 2014-04-30 | total_equity | 3,038,510,000 United States dollar | superseded | [clm_AC0D885D6FF5](/claim/clm_AC0D885D6FF5.md) - 2014-01-31 to 2014-04-30 | cash_and_equivalents | 781,635,000 United States dollar | superseded | [clm_C1B3EC5EC529](/claim/clm_C1B3EC5EC529.md) - 2014-02-01 to 2015-01-31 | operating_income | -145,633,000 United States dollar | superseded | [clm_007802794AEE](/claim/clm_007802794AEE.md) - 2014-02-01 to 2015-01-31 | net_income | -262,688,000 United States dollar | superseded | [clm_F8E998BAA108](/claim/clm_F8E998BAA108.md) - 2014-02-01 to 2015-01-31 | revenue | 5,373,586,000 United States dollar | superseded | [clm_FB3E64821A16](/claim/clm_FB3E64821A16.md) - 2014-04-30 to 2014-07-31 | quarterly_revenue | 1,226,772,000 United States dollar | superseded | [clm_0D62271DD055](/claim/clm_0D62271DD055.md) - 2014-04-30 to 2014-07-31 | quarterly_net_income | -96,911,000 United States dollar | superseded | [clm_0D9B468D3A82](/claim/clm_0D9B468D3A82.md) - 2014-04-30 to 2014-07-31 | quarterly_operating_income | -55,341,000 United States dollar | superseded | [clm_177DDCCC1C80](/claim/clm_177DDCCC1C80.md) - 2014-04-30 to 2014-07-31 | total_equity | 3,131,914,000 United States dollar | superseded | [clm_676CFCB34A27](/claim/clm_676CFCB34A27.md) - 2014-04-30 to 2014-07-31 | cash_and_equivalents | 827,891,000 United States dollar | superseded | [clm_77C1779BE36B](/claim/clm_77C1779BE36B.md) - 2014-04-30 to 2014-07-31 | shares_outstanding | 614,000,000 shares | superseded | [clm_8B7CF51EE1C3](/claim/clm_8B7CF51EE1C3.md) - 2014-04-30 to 2014-07-31 | total_assets | 8,641,344,000 United States dollar | superseded | [clm_B9DC6E8D1538](/claim/clm_B9DC6E8D1538.md) - 2014-04-30 to 2014-07-31 | quarterly_research_and_development | 188,358,000 United States dollar | superseded | [clm_E95D5A1EA235](/claim/clm_E95D5A1EA235.md) - 2014-07-31 to 2014-10-31 | quarterly_net_income | -61,088,000 United States dollar | superseded | [clm_15AEAA977DA0](/claim/clm_15AEAA977DA0.md) - 2014-07-31 to 2014-10-31 | quarterly_research_and_development | 203,109,000 United States dollar | superseded | [clm_44FB26FE6AA3](/claim/clm_44FB26FE6AA3.md) - 2014-07-31 to 2014-10-31 | cash_and_equivalents | 774,725,000 United States dollar | superseded | [clm_5CBBFE648155](/claim/clm_5CBBFE648155.md) - 2014-07-31 to 2014-10-31 | quarterly_revenue | 1,318,551,000 United States dollar | superseded | [clm_6BC293614625](/claim/clm_6BC293614625.md) - 2014-07-31 to 2014-10-31 | total_equity | 3,300,568,000 United States dollar | superseded | [clm_BB5227217113](/claim/clm_BB5227217113.md) - 2014-07-31 to 2014-10-31 | shares_outstanding | 619,000,000 shares | superseded | [clm_D517B52BDD51](/claim/clm_D517B52BDD51.md) - 2014-07-31 to 2014-10-31 | total_assets | 9,009,828,000 United States dollar | superseded | [clm_EEF1AF6CCC0E](/claim/clm_EEF1AF6CCC0E.md) - 2014-07-31 to 2014-10-31 | quarterly_operating_income | -33,434,000 United States dollar | superseded | [clm_F3263DABA162](/claim/clm_F3263DABA162.md) - 2014-10-31 to 2015-04-30 | quarterly_operating_income | -22,042,000 United States dollar | superseded | [clm_2160FCC47A17](/claim/clm_2160FCC47A17.md) - 2014-10-31 to 2015-01-31 | cash_and_equivalents | 846,325,000 United States dollar | superseded | [clm_361A29F0D6ED](/claim/clm_361A29F0D6ED.md) - 2014-10-31 to 2015-01-31 | shares_outstanding | 631,000,000 shares | superseded | [clm_89A59D8429C2](/claim/clm_89A59D8429C2.md) - 2014-10-31 to 2015-01-31 | total_equity | 3,790,614,000 United States dollar | superseded | [clm_A2655F5AAC0A](/claim/clm_A2655F5AAC0A.md) - 2014-10-31 to 2015-04-30 | quarterly_research_and_development | 195,460,000 United States dollar | superseded | [clm_C0B3B9C1004E](/claim/clm_C0B3B9C1004E.md) - 2014-10-31 to 2015-01-31 | total_assets | 9,412,663,000 United States dollar | superseded | [clm_CAB160FCDC2E](/claim/clm_CAB160FCDC2E.md) - 2014-10-31 to 2015-04-30 | quarterly_net_income | -38,924,000 United States dollar | superseded | [clm_F317028F0E3B](/claim/clm_F317028F0E3B.md) - 2014-10-31 to 2017-04-30 | quarterly_revenue | 1,383,655,000 United States dollar | superseded | [clm_FDD237768024](/claim/clm_FDD237768024.md) - 2014-12-31 to 2015-12-31 | employees | 13,300 | superseded | [clm_E6855AC35992](/claim/clm_E6855AC35992.md) ## 2015 - 2015-01-31 to 2015-04-30 | shares_outstanding | 650,600,000 shares | superseded | [clm_31633DF2EBCD](/claim/clm_31633DF2EBCD.md) - 2015-01-31 to 2015-04-30 | total_assets | 10,692,982,000 United States dollar | superseded | [clm_4CB0DA533143](/claim/clm_4CB0DA533143.md) - 2015-01-31 to 2016-01-31 | research_and_development | 792,917,000 United States dollar | superseded | [clm_6D66491747F2](/claim/clm_6D66491747F2.md) - 2015-01-31 to 2015-04-30 | cash_and_equivalents | 908,117,000 United States dollar | superseded | [clm_81BB3251568D](/claim/clm_81BB3251568D.md) - 2015-01-31 to 2015-04-30 | total_equity | 3,975,183,000 United States dollar | superseded | [clm_AB9886F42572](/claim/clm_AB9886F42572.md) - 2015-01-31 to 2015-02-01 | revenue | 5,373,586,000 United States dollar | superseded | [clm_B68163AD049F](/claim/clm_B68163AD049F.md) - 2015-01-31 to 2015-02-01 | net_income | -262,688,000 United States dollar | superseded | [clm_B9D2BA4559B0](/claim/clm_B9D2BA4559B0.md) - 2015-01-31 to 2015-02-01 | operating_income | -145,633,000 United States dollar | superseded | [clm_F4A761EEE0C1](/claim/clm_F4A761EEE0C1.md) - 2015-02-01 to 2016-01-31 | operating_income | 114,923,000 United States dollar | superseded | [clm_0D66681D47E3](/claim/clm_0D66681D47E3.md) - 2015-02-01 to 2016-01-31 | revenue | 6,667,216,000 United States dollar | superseded | [clm_46B164B677AB](/claim/clm_46B164B677AB.md) - 2015-02-01 to 2016-01-31 | net_income | -47,426,000 United States dollar | superseded | [clm_99676D60C3FF](/claim/clm_99676D60C3FF.md) - 2015-04-30 to 2015-07-31 | quarterly_research_and_development | 222,128,000 United States dollar | superseded | [clm_17345300E72A](/claim/clm_17345300E72A.md) - 2015-04-30 to 2015-07-31 | cash_and_equivalents | 941,956,000 United States dollar | superseded | [clm_422BA9027F2A](/claim/clm_422BA9027F2A.md) - 2015-04-30 to 2015-07-31 | quarterly_operating_income | 31,105,000 United States dollar | superseded | [clm_4C7AC3AC3D9B](/claim/clm_4C7AC3AC3D9B.md) - 2015-04-30 to 2015-07-31 | quarterly_net_income | 4,092,000 United States dollar | superseded | [clm_A01F6832DD59](/claim/clm_A01F6832DD59.md) - 2015-04-30 to 2015-07-31 | shares_outstanding | 656,000,000 shares | superseded | [clm_D454131A9DE5](/claim/clm_D454131A9DE5.md) - 2015-04-30 to 2015-07-31 | total_assets | 10,365,682,000 United States dollar | superseded | [clm_D779EEDDADE0](/claim/clm_D779EEDDADE0.md) - 2015-04-30 to 2015-07-31 | total_equity | 4,235,203,000 United States dollar | superseded | [clm_DF63CCA5E7C3](/claim/clm_DF63CCA5E7C3.md) - 2015-07-31 to 2015-10-31 | quarterly_operating_income | 19,824,000 United States dollar | superseded | [clm_1A3CC29551F9](/claim/clm_1A3CC29551F9.md) - 2015-07-31 to 2015-10-31 | total_equity | 4,535,803,000 United States dollar | superseded | [clm_2C4B619951CA](/claim/clm_2C4B619951CA.md) - 2015-07-31 to 2015-10-31 | quarterly_research_and_development | 234,100,000 United States dollar | superseded | [clm_593D6F72A2F2](/claim/clm_593D6F72A2F2.md) - 2015-07-31 to 2015-10-31 | cash_and_equivalents | 1,089,351,000 United States dollar | superseded | [clm_60280AD50BC5](/claim/clm_60280AD50BC5.md) - 2015-07-31 to 2015-10-31 | quarterly_net_income | -852,000 United States dollar | superseded | [clm_C28C0A6FAE6A](/claim/clm_C28C0A6FAE6A.md) - 2015-07-31 to 2015-10-31 | total_assets | 10,793,977,000 United States dollar | superseded | [clm_CDD1784AAB95](/claim/clm_CDD1784AAB95.md) - 2015-07-31 to 2015-10-31 | shares_outstanding | 660,000,000 shares | superseded | [clm_D8B663326C79](/claim/clm_D8B663326C79.md) - 2015-10-31 to 2016-01-31 | cash_and_equivalents | 1,223,318,000 United States dollar | superseded | [clm_28538B425495](/claim/clm_28538B425495.md) - 2015-10-31 to 2016-04-30 | quarterly_net_income | -25,157,000 United States dollar | superseded | [clm_433643045C97](/claim/clm_433643045C97.md) - 2015-10-31 to 2016-01-31 | shares_outstanding | 664,000,000 shares | superseded | [clm_5E5387E8B021](/claim/clm_5E5387E8B021.md) - 2015-10-31 to 2016-01-31 | total_equity | 4,749,954,000 United States dollar | superseded | [clm_8F29E882858E](/claim/clm_8F29E882858E.md) - 2015-10-31 to 2016-04-30 | quarterly_research_and_development | 239,212,000 United States dollar | superseded | [clm_E12F33B9D5BF](/claim/clm_E12F33B9D5BF.md) - 2015-10-31 to 2016-01-31 | total_assets | 10,911,966,000 United States dollar | superseded | [clm_E223A7897D59](/claim/clm_E223A7897D59.md) - 2015-10-31 to 2016-04-30 | quarterly_operating_income | 43,434,000 United States dollar | superseded | [clm_E8D6AAA0AE71](/claim/clm_E8D6AAA0AE71.md) - 2015-12-31 to 2016-12-31 | employees | 16,000 | superseded | [clm_2810941F5133](/claim/clm_2810941F5133.md) ## 2016 - 2016-01-31 to 2017-01-31 | research_and_development | 946,300,000 United States dollar | superseded | [clm_17BC77DDD0E2](/claim/clm_17BC77DDD0E2.md) - 2016-01-31 to 2016-04-30 | shares_outstanding | 670,900,000 shares | superseded | [clm_355BB3714431](/claim/clm_355BB3714431.md) - 2016-01-31 to 2016-02-01 | operating_income | 114,923,000 United States dollar | superseded | [clm_38BA67CC4D95](/claim/clm_38BA67CC4D95.md) - 2016-01-31 to 2016-02-01 | revenue | 6,667,216,000 United States dollar | superseded | [clm_4CEE5D2AC493](/claim/clm_4CEE5D2AC493.md) - 2016-01-31 to 2016-02-01 | net_income | -47,426,000 United States dollar | superseded | [clm_79E76587A341](/claim/clm_79E76587A341.md) - 2016-01-31 to 2016-04-30 | total_equity | 5,002,869,000 United States dollar | superseded | [clm_80060EBED69E](/claim/clm_80060EBED69E.md) - 2016-01-31 to 2016-04-30 | cash_and_equivalents | 1,158,363,000 United States dollar | superseded | [clm_8D4063552737](/claim/clm_8D4063552737.md) - 2016-01-31 to 2016-04-30 | total_assets | 12,770,772,000 United States dollar | superseded | [clm_D1D8EFD5C1B2](/claim/clm_D1D8EFD5C1B2.md) - 2016-02-01 to 2017-01-31 | operating_income | 64,228,000 United States dollar | superseded | [clm_0F50F35E7B5A](/claim/clm_0F50F35E7B5A.md) - 2016-02-01 to 2017-01-31 | net_income | 179,632,000 United States dollar | superseded | [clm_190C0B66784C](/claim/clm_190C0B66784C.md) - 2016-02-01 to 2017-01-31 | revenue | 8,391,984,000 United States dollar | superseded | [clm_B9DCC0F577C0](/claim/clm_B9DCC0F577C0.md) - 2016-04-30 to 2016-07-31 | total_assets | 12,817,270,000 United States dollar | superseded | [clm_52665633C024](/claim/clm_52665633C024.md) - 2016-04-30 to 2016-07-31 | quarterly_operating_income | 51,986,000 United States dollar | superseded | [clm_5EDCA30EFDF7](/claim/clm_5EDCA30EFDF7.md) - 2016-04-30 to 2016-07-31 | total_equity | 5,584,264,000 United States dollar | superseded | [clm_6A052BEC3CB7](/claim/clm_6A052BEC3CB7.md) - 2016-04-30 to 2016-07-31 | quarterly_research_and_development | 260,970,000 United States dollar | superseded | [clm_B32C22DC9CF4](/claim/clm_B32C22DC9CF4.md) - 2016-04-30 to 2016-07-31 | shares_outstanding | 677,500,000 shares | superseded | [clm_D749DC5610AA](/claim/clm_D749DC5610AA.md) - 2016-04-30 to 2016-07-31 | cash_and_equivalents | 1,799,083,000 United States dollar | superseded | [clm_F0DF5D750010](/claim/clm_F0DF5D750010.md) - 2016-04-30 to 2016-07-31 | quarterly_net_income | 38,759,000 United States dollar | superseded | [clm_F935694DA8B2](/claim/clm_F935694DA8B2.md) - 2016-07-31 to 2016-10-31 | quarterly_operating_income | 32,551,000 United States dollar | superseded | [clm_0158B140CD97](/claim/clm_0158B140CD97.md) - 2016-07-31 to 2016-10-31 | quarterly_net_income | 229,622,000 United States dollar | superseded | [clm_14088FFB3E43](/claim/clm_14088FFB3E43.md) - 2016-07-31 to 2016-10-31 | quarterly_research_and_development | 291,506,000 United States dollar | superseded | [clm_343BFC0DAAA9](/claim/clm_343BFC0DAAA9.md) - 2016-07-31 to 2016-10-31 | total_assets | 14,381,314,000 United States dollar | superseded | [clm_AAAADBF13DAE](/claim/clm_AAAADBF13DAE.md) - 2016-07-31 to 2016-10-31 | total_equity | 6,132,576,000 United States dollar | superseded | [clm_D8FE826D5AB7](/claim/clm_D8FE826D5AB7.md) - 2016-07-31 to 2016-10-31 | shares_outstanding | 685,000,000 shares | superseded | [clm_DB8CC3675CD6](/claim/clm_DB8CC3675CD6.md) - 2016-07-31 to 2016-10-31 | cash_and_equivalents | 1,115,226,000 United States dollar | superseded | [clm_DF0ADADABE7E](/claim/clm_DF0ADADABE7E.md) - 2016-10-31 to 2017-01-31 | cash_and_equivalents | 1,145,736,000 United States dollar | superseded | [clm_12837C5B362C](/claim/clm_12837C5B362C.md) - 2016-10-31 to 2017-01-31 | total_equity | 6,806,037,000 United States dollar | superseded | [clm_6FE2BD76C227](/claim/clm_6FE2BD76C227.md) - 2016-10-31 to 2017-01-31 | shares_outstanding | 696,700,000 shares | superseded | [clm_7D421A369600](/claim/clm_7D421A369600.md) - 2016-10-31 to 2017-04-30 | quarterly_research_and_development | 311,459,000 United States dollar | superseded | [clm_952D1C139ACE](/claim/clm_952D1C139ACE.md) - 2016-10-31 to 2017-04-30 | quarterly_net_income | -37,309,000 United States dollar | superseded | [clm_CF8935CD789E](/claim/clm_CF8935CD789E.md) - 2016-10-31 to 2017-01-31 | total_assets | 14,387,669,000 United States dollar | superseded | [clm_DF924D9092B2](/claim/clm_DF924D9092B2.md) - 2016-10-31 to 2017-04-30 | quarterly_operating_income | 3,036,000 United States dollar | superseded | [clm_EBBCEF220F87](/claim/clm_EBBCEF220F87.md) - 2016-12-31 to 2017-12-31 | employees | 19,000 | superseded | [clm_E880D873D793](/claim/clm_E880D873D793.md) ## 2017 - 2017-01-31 to 2017-02-01 | operating_income | 64,228,000 United States dollar | superseded | [clm_1628CD507B06](/claim/clm_1628CD507B06.md) - 2017-01-31 to 2017-04-30 | total_assets | 17,584,923,000 United States dollar | superseded | [clm_6172529B0224](/claim/clm_6172529B0224.md) - 2017-01-31 to 2017-04-30 | shares_outstanding | 707,500,000 shares | superseded | [clm_628B2EC9E7AD](/claim/clm_628B2EC9E7AD.md) - 2017-01-31 to 2017-04-30 | total_equity | 7,500,127,000 United States dollar | superseded | [clm_7B65C7D97B64](/claim/clm_7B65C7D97B64.md) - 2017-01-31 to 2017-02-01 | revenue | 8,391,984,000 United States dollar | superseded | [clm_959FFFEDF948](/claim/clm_959FFFEDF948.md) - 2017-01-31 to 2017-02-01 | net_income | 179,632,000 United States dollar | superseded | [clm_BD22A45C29F3](/claim/clm_BD22A45C29F3.md) - 2017-01-31 to 2018-01-31 | research_and_development | 1,208,127,000 United States dollar | superseded | [clm_C8E78BB3F9EC](/claim/clm_C8E78BB3F9EC.md) - 2017-01-31 to 2017-04-30 | cash_and_equivalents | 1,606,549,000 United States dollar | superseded | [clm_EF0A01294781](/claim/clm_EF0A01294781.md) - 2017-02-01 to 2018-01-31 | revenue | 10,540,000,000 United States dollar | superseded | [clm_4A659F16A336](/claim/clm_4A659F16A336.md) - 2017-02-01 to 2018-01-31 | net_income | 127,478,000 United States dollar | superseded | [clm_8E9576EFAB50](/claim/clm_8E9576EFAB50.md) - 2017-02-01 to 2018-01-31 | operating_income | 235,768,000 United States dollar | superseded | [clm_BCCF77AD6089](/claim/clm_BCCF77AD6089.md) - 2017-04-30 to 2017-07-31 | cash_and_equivalents | 2,024,904,000 United States dollar | superseded | [clm_0CC679AF09B8](/claim/clm_0CC679AF09B8.md) - 2017-04-30 to 2017-07-31 | quarterly_net_income | -9,207,000 United States dollar | superseded | [clm_1D2397C3DD82](/claim/clm_1D2397C3DD82.md) - 2017-04-30 to 2017-07-31 | total_equity | 7,934,488,000 United States dollar | superseded | [clm_649ABBFDBCC8](/claim/clm_649ABBFDBCC8.md) - 2017-04-30 to 2017-07-31 | quarterly_revenue | 2,397,000,000 United States dollar | superseded | [clm_86D888D5B72A](/claim/clm_86D888D5B72A.md) - 2017-04-30 to 2017-07-31 | quarterly_research_and_development | 376,081,000 United States dollar | superseded | [clm_9881822B6086](/claim/clm_9881822B6086.md) - 2017-04-30 to 2017-07-31 | total_assets | 17,058,930,000 United States dollar | superseded | [clm_9D3FE45D7BAA](/claim/clm_9D3FE45D7BAA.md) - 2017-04-30 to 2017-07-31 | shares_outstanding | 712,200,000 shares | superseded | [clm_A747624BACBB](/claim/clm_A747624BACBB.md) - 2017-04-30 to 2017-07-31 | quarterly_operating_income | -8,882,000 United States dollar | superseded | [clm_B0A09CC4D057](/claim/clm_B0A09CC4D057.md) - 2017-07-31 to 2017-10-31 | cash_and_equivalents | 1,949,110,000 United States dollar | superseded | [clm_0F4B68564CC5](/claim/clm_0F4B68564CC5.md) - 2017-07-31 to 2017-10-31 | total_assets | 17,418,803,000 United States dollar | superseded | [clm_2FF4AD4F664C](/claim/clm_2FF4AD4F664C.md) - 2017-07-31 to 2017-10-31 | quarterly_operating_income | 50,793,000 United States dollar | superseded | [clm_4B33BCF4276A](/claim/clm_4B33BCF4276A.md) - 2017-07-31 to 2017-10-31 | quarterly_net_income | 17,736,000 United States dollar | superseded | [clm_5B7091CC81DC](/claim/clm_5B7091CC81DC.md) - 2017-07-31 to 2017-10-31 | total_equity | 8,451,314,000 United States dollar | superseded | [clm_98F653ADD1D0](/claim/clm_98F653ADD1D0.md) - 2017-07-31 to 2017-10-31 | quarterly_research_and_development | 386,447,000 United States dollar | superseded | [clm_9E829DE8F71E](/claim/clm_9E829DE8F71E.md) - 2017-07-31 to 2017-10-31 | shares_outstanding | 718,700,000 shares | superseded | [clm_A6AF44EAC006](/claim/clm_A6AF44EAC006.md) - 2017-07-31 to 2017-10-31 | quarterly_revenue | 2,577,000,000 United States dollar | superseded | [clm_C70110F4EBA0](/claim/clm_C70110F4EBA0.md) - 2017-08-22 | x_username | SalesforceNews | unverified | [clm_0094DEC09009](/claim/clm_0094DEC09009.md) - 2017-10-31 to 2018-04-30 | quarterly_operating_income | 115,988,000 United States dollar | superseded | [clm_1B50F82906DF](/claim/clm_1B50F82906DF.md) - 2017-10-31 to 2018-04-30 | quarterly_net_income | 51,394,000 United States dollar | superseded | [clm_5B1C65FECD00](/claim/clm_5B1C65FECD00.md) - 2017-10-31 to 2018-04-30 | quarterly_research_and_development | 393,998,000 United States dollar | superseded | [clm_8B6A668337F3](/claim/clm_8B6A668337F3.md) - 2017-10-31 to 2018-01-31 | cash_and_equivalents | 2,071,837,000 United States dollar | superseded | [clm_8D8AA0F89159](/claim/clm_8D8AA0F89159.md) - 2017-10-31 to 2018-01-31 | total_assets | 17,490,036,000 United States dollar | superseded | [clm_900C9F5C4FF7](/claim/clm_900C9F5C4FF7.md) - 2017-10-31 to 2018-01-31 | total_equity | 8,829,370,000 United States dollar | superseded | [clm_A339C363A477](/claim/clm_A339C363A477.md) - 2017-10-31 to 2018-04-30 | quarterly_revenue | 2,701,000,000 United States dollar | superseded | [clm_FC45BE368546](/claim/clm_FC45BE368546.md) - 2017-10-31 to 2018-02-28 | shares_outstanding | 722,300,000 shares | superseded | [clm_FE2992A7CEBD](/claim/clm_FE2992A7CEBD.md) - 2017-12-31 to 2018-12-31 | employees | 25,000 | superseded | [clm_0FA3C46AD645](/claim/clm_0FA3C46AD645.md) ## 2018 - 2018-01-31 to 2019-01-31 | research_and_development | 1,553,073,000 United States dollar | superseded | [clm_2306B466A286](/claim/clm_2306B466A286.md) - 2018-01-31 to 2018-04-30 | total_assets | 21,009,802,000 United States dollar | superseded | [clm_299C060F57ED](/claim/clm_299C060F57ED.md) - 2018-01-31 to 2018-02-01 | revenue | 10,540,000,000 United States dollar | superseded | [clm_3736F890C475](/claim/clm_3736F890C475.md) - 2018-01-31 to 2018-04-30 | total_equity | 9,388,496,000 United States dollar | superseded | [clm_6B3E41A0DF21](/claim/clm_6B3E41A0DF21.md) - 2018-01-31 to 2018-04-30 | cash_and_equivalents | 2,543,484,000 United States dollar | superseded | [clm_B330F1631743](/claim/clm_B330F1631743.md) - 2018-01-31 to 2018-02-01 | net_income | 127,478,000 United States dollar | superseded | [clm_B6F5123411EA](/claim/clm_B6F5123411EA.md) - 2018-01-31 to 2018-02-01 | operating_income | 235,768,000 United States dollar | superseded | [clm_B8384CC972EB](/claim/clm_B8384CC972EB.md) - 2018-02-01 to 2019-01-31 | operating_income | 535,000,000 United States dollar | superseded | [clm_B856BC618027](/claim/clm_B856BC618027.md) - 2018-02-01 to 2019-01-31 | revenue | 13,282,000,000 United States dollar | superseded | [clm_BA01AC15C7DB](/claim/clm_BA01AC15C7DB.md) - 2018-02-01 to 2019-01-31 | net_income | 1,110,000,000 United States dollar | superseded | [clm_FAA17912CD6E](/claim/clm_FAA17912CD6E.md) - 2018-02-28 to 2018-04-30 | shares_outstanding | 731,500,000 shares | superseded | [clm_823F1D9E1556](/claim/clm_823F1D9E1556.md) - 2018-04-30 to 2018-07-31 | quarterly_net_income | 344,000,000 United States dollar | superseded | [clm_5E0DA3B0755B](/claim/clm_5E0DA3B0755B.md) - 2018-04-30 to 2018-07-31 | shares_outstanding | 733,900,000 shares | superseded | [clm_833C412C5B72](/claim/clm_833C412C5B72.md) - 2018-04-30 to 2018-07-31 | quarterly_operating_income | 191,000,000 United States dollar | superseded | [clm_9C1820913A89](/claim/clm_9C1820913A89.md) - 2018-04-30 to 2018-07-31 | total_assets | 22,963,000,000 United States dollar | superseded | [clm_BA9A0B6127C6](/claim/clm_BA9A0B6127C6.md) - 2018-04-30 to 2018-07-31 | cash_and_equivalents | 5,922,000,000 United States dollar | superseded | [clm_D087B1AFE5AC](/claim/clm_D087B1AFE5AC.md) - 2018-04-30 to 2018-07-31 | total_equity | 11,060,000,000 United States dollar | superseded | [clm_D213C640DDFD](/claim/clm_D213C640DDFD.md) - 2018-04-30 to 2018-07-31 | quarterly_revenue | 3,006,000,000 United States dollar | superseded | [clm_E270A3761B10](/claim/clm_E270A3761B10.md) - 2018-04-30 to 2018-07-31 | quarterly_research_and_development | 424,000,000 United States dollar | superseded | [clm_F78DC41D5ED4](/claim/clm_F78DC41D5ED4.md) - 2018-07-31 to 2018-10-31 | quarterly_revenue | 3,281,000,000 United States dollar | superseded | [clm_287D26A6AC8C](/claim/clm_287D26A6AC8C.md) - 2018-07-31 to 2018-10-31 | quarterly_research_and_development | 463,000,000 United States dollar | superseded | [clm_373109038323](/claim/clm_373109038323.md) - 2018-07-31 to 2018-10-31 | quarterly_operating_income | 115,000,000 United States dollar | superseded | [clm_5084395EFB48](/claim/clm_5084395EFB48.md) - 2018-07-31 to 2018-10-31 | quarterly_net_income | 299,000,000 United States dollar | superseded | [clm_65D7B8EC3778](/claim/clm_65D7B8EC3778.md) - 2018-07-31 to 2018-10-31 | shares_outstanding | 756,700,000 shares | superseded | [clm_97995AC82644](/claim/clm_97995AC82644.md) - 2018-07-31 to 2018-10-31 | cash_and_equivalents | 2,319,000,000 United States dollar | superseded | [clm_B091DCFB617D](/claim/clm_B091DCFB617D.md) - 2018-07-31 to 2018-10-31 | total_equity | 13,528,000,000 United States dollar | superseded | [clm_C4084F3EF247](/claim/clm_C4084F3EF247.md) - 2018-07-31 to 2018-10-31 | total_assets | 25,823,000,000 United States dollar | superseded | [clm_DD4AA7D4C698](/claim/clm_DD4AA7D4C698.md) - 2018-10-31 to 2019-01-31 | cash_and_equivalents | 2,105,000,000 United States dollar | superseded | [clm_0EBE7995925A](/claim/clm_0EBE7995925A.md) - 2018-10-31 to 2019-02-28 | shares_outstanding | 765,000,000 shares | superseded | [clm_25D4DBAB13C8](/claim/clm_25D4DBAB13C8.md) - 2018-10-31 to 2019-04-30 | quarterly_net_income | 105,000,000 United States dollar | superseded | [clm_48B57BE5E00C](/claim/clm_48B57BE5E00C.md) - 2018-10-31 to 2019-01-31 | total_assets | 26,588,000,000 United States dollar | superseded | [clm_5229B426D22D](/claim/clm_5229B426D22D.md) - 2018-10-31 to 2019-01-31 | total_equity | 14,693,000,000 United States dollar | superseded | [clm_B1A254EF2366](/claim/clm_B1A254EF2366.md) - 2018-10-31 to 2019-04-30 | quarterly_operating_income | 92,000,000 United States dollar | superseded | [clm_CC6C09A692EB](/claim/clm_CC6C09A692EB.md) - 2018-10-31 to 2019-04-30 | quarterly_revenue | 3,392,000,000 United States dollar | superseded | [clm_F22D7C70A02B](/claim/clm_F22D7C70A02B.md) - 2018-10-31 to 2019-04-30 | quarterly_research_and_development | 481,000,000 United States dollar | superseded | [clm_FE6C2311A5DC](/claim/clm_FE6C2311A5DC.md) - 2018-12-31 to 2019-01-31 | employees | 29,000 | superseded | [clm_9171C6972699](/claim/clm_9171C6972699.md) ## 2019 - 2019-01-31 to 2019-04-30 | cash_and_equivalents | 2,669,000,000 United States dollar | superseded | [clm_0D639AD229E2](/claim/clm_0D639AD229E2.md) - 2019-01-31 to 2019-02-01 | revenue | 13,282,000,000 United States dollar | superseded | [clm_2CE644F47A19](/claim/clm_2CE644F47A19.md) - 2019-01-31 to 2019-04-30 | total_equity | 15,605,000,000 United States dollar | superseded | [clm_5322E3CF8DEE](/claim/clm_5322E3CF8DEE.md) - 2019-01-31 to 2026-01-31 | employees | 35,000 | superseded | [clm_C4E58E25E9CC](/claim/clm_C4E58E25E9CC.md) - 2019-01-31 to 2019-02-01 | operating_income | 535,000,000 United States dollar | superseded | [clm_C7EAE065F9CF](/claim/clm_C7EAE065F9CF.md) - 2019-01-31 to 2019-02-01 | net_income | 1,110,000,000 United States dollar | superseded | [clm_D246B222AF04](/claim/clm_D246B222AF04.md) - 2019-01-31 to 2020-01-31 | research_and_development | 1,886,000,000 United States dollar | superseded | [clm_DC8A12086670](/claim/clm_DC8A12086670.md) - 2019-01-31 to 2019-04-30 | total_assets | 30,737,000,000 United States dollar | superseded | [clm_EA9BF562A59D](/claim/clm_EA9BF562A59D.md) - 2019-02-01 to 2020-01-31 | net_income | 126,000,000 United States dollar | superseded | [clm_4E270BAB0582](/claim/clm_4E270BAB0582.md) - 2019-02-01 to 2020-01-31 | revenue | 17,098,000,000 United States dollar | superseded | [clm_890681F8B9B4](/claim/clm_890681F8B9B4.md) - 2019-02-01 to 2020-01-31 | operating_income | 297,000,000 United States dollar | superseded | [clm_E14A154FC750](/claim/clm_E14A154FC750.md) - 2019-02-28 to 2019-05-31 | shares_outstanding | 771,000,000 shares | superseded | [clm_65A6D9985040](/claim/clm_65A6D9985040.md) - 2019-04-30 to 2019-07-31 | cash_and_equivalents | 4,110,000,000 United States dollar | superseded | [clm_37E4F120F41C](/claim/clm_37E4F120F41C.md) - 2019-04-30 to 2019-07-31 | total_equity | 16,446,000,000 United States dollar | superseded | [clm_463DF81B3E4F](/claim/clm_463DF81B3E4F.md) - 2019-04-30 to 2019-07-31 | total_assets | 33,154,000,000 United States dollar | superseded | [clm_806590F291F0](/claim/clm_806590F291F0.md) - 2019-04-30 to 2019-07-31 | quarterly_revenue | 3,737,000,000 United States dollar | superseded | [clm_91EC09B62DC6](/claim/clm_91EC09B62DC6.md) - 2019-04-30 to 2019-07-31 | quarterly_net_income | 392,000,000 United States dollar | superseded | [clm_A998CC803A76](/claim/clm_A998CC803A76.md) - 2019-04-30 to 2019-07-31 | quarterly_operating_income | 210,000,000 United States dollar | superseded | [clm_E5D4628948A6](/claim/clm_E5D4628948A6.md) - 2019-04-30 to 2019-07-31 | quarterly_research_and_development | 554,000,000 United States dollar | superseded | [clm_E6AAA1C99D25](/claim/clm_E6AAA1C99D25.md) - 2019-05-31 to 2019-08-15 | shares_outstanding | 776,000,000 shares | superseded | [clm_B69508A9CB11](/claim/clm_B69508A9CB11.md) - 2019-06-14 to 2022-03-31 | registrant_name | SALESFORCE.COM, INC. | superseded | [clm_B714412D26CD](/claim/clm_B714412D26CD.md) - 2019-07-31 to 2019-10-31 | cash_and_equivalents | 3,510,000,000 United States dollar | superseded | [clm_66D20870F1AD](/claim/clm_66D20870F1AD.md) - 2019-07-31 to 2019-10-31 | quarterly_net_income | 91,000,000 United States dollar | superseded | [clm_770988FC2248](/claim/clm_770988FC2248.md) - 2019-07-31 to 2019-10-31 | quarterly_research_and_development | 607,000,000 United States dollar | superseded | [clm_8889B5BA660D](/claim/clm_8889B5BA660D.md) - 2019-07-31 to 2019-10-31 | quarterly_revenue | 3,997,000,000 United States dollar | superseded | [clm_B5185539998E](/claim/clm_B5185539998E.md) - 2019-07-31 to 2019-10-31 | total_assets | 33,336,000,000 United States dollar | superseded | [clm_BA9F45BF7F52](/claim/clm_BA9F45BF7F52.md) - 2019-07-31 to 2019-10-31 | quarterly_operating_income | 58,000,000 United States dollar | superseded | [clm_FBE277A2A888](/claim/clm_FBE277A2A888.md) - 2019-07-31 to 2019-10-31 | total_equity | 17,166,000,000 United States dollar | superseded | [clm_FE826B6A85F9](/claim/clm_FE826B6A85F9.md) - 2019-08-15 to 2019-11-29 | shares_outstanding | 877,000,000 shares | superseded | [clm_E0CC08196648](/claim/clm_E0CC08196648.md) - 2019-10-31 to 2020-04-30 | quarterly_revenue | 4,513,000,000 United States dollar | superseded | [clm_01F740A2CEEA](/claim/clm_01F740A2CEEA.md) - 2019-10-31 to 2020-04-30 | quarterly_research_and_development | 774,000,000 United States dollar | superseded | [clm_217A1D996298](/claim/clm_217A1D996298.md) - 2019-10-31 to 2020-04-30 | quarterly_operating_income | 65,000,000 United States dollar | superseded | [clm_5EA2AD1C5B5A](/claim/clm_5EA2AD1C5B5A.md) - 2019-10-31 to 2020-01-31 | cash_and_equivalents | 3,868,000,000 United States dollar | superseded | [clm_D82FE1AC4D6F](/claim/clm_D82FE1AC4D6F.md) - 2019-10-31 to 2020-04-30 | quarterly_net_income | -109,000,000 United States dollar | superseded | [clm_EBFCBA718F99](/claim/clm_EBFCBA718F99.md) - 2019-10-31 to 2020-01-31 | total_assets | 49,942,000,000 United States dollar | superseded | [clm_F4B5D50FFC93](/claim/clm_F4B5D50FFC93.md) - 2019-10-31 to 2020-01-31 | total_equity | 33,279,000,000 United States dollar | superseded | [clm_FAE2CD5D0AE2](/claim/clm_FAE2CD5D0AE2.md) - 2019-11-29 to 2020-02-29 | shares_outstanding | 887,000,000 shares | superseded | [clm_8D75667B5363](/claim/clm_8D75667B5363.md) - 2019-12-31 to 2019-12-31 | employees | 35,000 | superseded | [clm_EDCC6AE6EFB2](/claim/clm_EDCC6AE6EFB2.md) ## 2020 - 2020-01-31 to 2020-04-30 | total_equity | 33,885,000,000 United States dollar | superseded | [clm_099146A1007B](/claim/clm_099146A1007B.md) - 2020-01-31 to 2020-04-30 | total_assets | 55,126,000,000 United States dollar | superseded | [clm_B491AEC89954](/claim/clm_B491AEC89954.md) - 2020-01-31 to 2020-02-01 | revenue | 17,098,000,000 United States dollar | superseded | [clm_C043DAD9ADBA](/claim/clm_C043DAD9ADBA.md) - 2020-01-31 to 2020-04-30 | cash_and_equivalents | 4,145,000,000 United States dollar | superseded | [clm_C9525529DA3A](/claim/clm_C9525529DA3A.md) - 2020-01-31 to 2020-02-01 | operating_income | 297,000,000 United States dollar | superseded | [clm_D8E52B9B5E86](/claim/clm_D8E52B9B5E86.md) - 2020-01-31 to 2020-02-01 | net_income | 126,000,000 United States dollar | superseded | [clm_F1DCED209499](/claim/clm_F1DCED209499.md) - 2020-01-31 to 2021-01-31 | research_and_development | 2,766,000,000 United States dollar | superseded | [clm_FB5F20261FE3](/claim/clm_FB5F20261FE3.md) - 2020-02-01 to 2021-01-31 | operating_income | 455,000,000 United States dollar | superseded | [clm_7CEE1626FFBF](/claim/clm_7CEE1626FFBF.md) - 2020-02-01 to 2021-01-31 | net_income | 4,072,000,000 United States dollar | superseded | [clm_812888AD2FF0](/claim/clm_812888AD2FF0.md) - 2020-02-01 to 2021-01-31 | revenue | 21,252,000,000 United States dollar | superseded | [clm_A86CCF056756](/claim/clm_A86CCF056756.md) - 2020-02-29 to 2020-05-29 | shares_outstanding | 895,000,000 shares | superseded | [clm_C152EFBEE5D8](/claim/clm_C152EFBEE5D8.md) - 2020-04-30 to 2020-07-31 | quarterly_research_and_development | 859,000,000 United States dollar | superseded | [clm_005C0DB0B679](/claim/clm_005C0DB0B679.md) - 2020-04-30 to 2020-07-31 | total_assets | 53,623,000,000 United States dollar | superseded | [clm_30E67931DABC](/claim/clm_30E67931DABC.md) - 2020-04-30 to 2020-07-31 | total_equity | 34,565,000,000 United States dollar | superseded | [clm_5271BAE51D3B](/claim/clm_5271BAE51D3B.md) - 2020-04-30 to 2020-07-31 | quarterly_net_income | 99,000,000 United States dollar | superseded | [clm_6FEB96717870](/claim/clm_6FEB96717870.md) - 2020-04-30 to 2020-07-31 | cash_and_equivalents | 5,772,000,000 United States dollar | superseded | [clm_9F712E220EE5](/claim/clm_9F712E220EE5.md) - 2020-04-30 to 2020-07-31 | quarterly_operating_income | -140,000,000 United States dollar | superseded | [clm_B4D4E4FA2558](/claim/clm_B4D4E4FA2558.md) - 2020-04-30 to 2020-07-31 | quarterly_revenue | 4,865,000,000 United States dollar | superseded | [clm_EE3C2044CEBB](/claim/clm_EE3C2044CEBB.md) - 2020-05-29 to 2020-08-25 | shares_outstanding | 901,000,000 shares | superseded | [clm_2DC8FF588F74](/claim/clm_2DC8FF588F74.md) - 2020-07-31 to 2020-10-31 | quarterly_revenue | 5,151,000,000 United States dollar | superseded | [clm_03EA0AB9D798](/claim/clm_03EA0AB9D798.md) - 2020-07-31 to 2020-10-31 | quarterly_net_income | 2,625,000,000 United States dollar | superseded | [clm_169344F4186D](/claim/clm_169344F4186D.md) - 2020-07-31 to 2020-10-31 | quarterly_operating_income | 178,000,000 United States dollar | superseded | [clm_5F7117EF52FE](/claim/clm_5F7117EF52FE.md) - 2020-07-31 to 2020-10-31 | quarterly_research_and_development | 898,000,000 United States dollar | superseded | [clm_BB8D8F982727](/claim/clm_BB8D8F982727.md) - 2020-07-31 to 2020-10-31 | cash_and_equivalents | 4,052,000,000 United States dollar | superseded | [clm_C23965B1D6AD](/claim/clm_C23965B1D6AD.md) - 2020-07-31 to 2020-10-31 | total_assets | 57,780,000,000 United States dollar | superseded | [clm_CCD7568A6DBD](/claim/clm_CCD7568A6DBD.md) - 2020-07-31 to 2020-10-31 | total_equity | 38,440,000,000 United States dollar | superseded | [clm_EB374CAF326D](/claim/clm_EB374CAF326D.md) - 2020-08-25 to 2020-12-01 | shares_outstanding | 910,000,000 shares | superseded | [clm_C9ADFDAFEFB2](/claim/clm_C9ADFDAFEFB2.md) - 2020-10-31 to 2021-04-30 | quarterly_operating_income | 224,000,000 United States dollar | superseded | [clm_05B937F7DB46](/claim/clm_05B937F7DB46.md) - 2020-10-31 to 2021-01-31 | total_assets | 59,136,000,000 United States dollar | superseded | [clm_1DCB9CF046DE](/claim/clm_1DCB9CF046DE.md) - 2020-10-31 to 2021-04-30 | quarterly_net_income | 1,081,000,000 United States dollar | superseded | [clm_45E6E631D502](/claim/clm_45E6E631D502.md) - 2020-10-31 to 2021-04-30 | quarterly_revenue | 5,419,000,000 United States dollar | superseded | [clm_66D321BA2E6B](/claim/clm_66D321BA2E6B.md) - 2020-10-31 to 2021-01-31 | total_equity | 40,310,000,000 United States dollar | superseded | [clm_745006B4F96C](/claim/clm_745006B4F96C.md) - 2020-10-31 to 2021-04-30 | quarterly_research_and_development | 902,000,000 United States dollar | superseded | [clm_B892646AC555](/claim/clm_B892646AC555.md) - 2020-10-31 to 2021-01-31 | cash_and_equivalents | 3,724,000,000 United States dollar | superseded | [clm_BC7BC8ECC906](/claim/clm_BC7BC8ECC906.md) - 2020-12-01 to 2021-03-15 | shares_outstanding | 915,000,000 shares | superseded | [clm_5F94EFDF875E](/claim/clm_5F94EFDF875E.md) ## 2021 - 2021-01-31 to 2021-04-30 | total_equity | 41,493,000,000 United States dollar | superseded | [clm_28BB60277558](/claim/clm_28BB60277558.md) - 2021-01-31 to 2022-01-31 | research_and_development | 3,598,000,000 United States dollar | superseded | [clm_351FF6AF74EE](/claim/clm_351FF6AF74EE.md) - 2021-01-31 to 2021-02-01 | revenue | 21,252,000,000 United States dollar | superseded | [clm_37D367C189EC](/claim/clm_37D367C189EC.md) - 2021-01-31 to 2021-04-30 | total_assets | 66,301,000,000 United States dollar | superseded | [clm_5DF2BF07AD51](/claim/clm_5DF2BF07AD51.md) - 2021-01-31 to 2021-02-01 | net_income | 4,072,000,000 United States dollar | superseded | [clm_B9EB261EA6E6](/claim/clm_B9EB261EA6E6.md) - 2021-01-31 to 2021-02-01 | operating_income | 455,000,000 United States dollar | superseded | [clm_BC47E2FB8710](/claim/clm_BC47E2FB8710.md) - 2021-01-31 to 2021-04-30 | cash_and_equivalents | 6,195,000,000 United States dollar | superseded | [clm_DB3A1C67ED9D](/claim/clm_DB3A1C67ED9D.md) - 2021-02-01 to 2022-01-31 | revenue | 26,492,000,000 United States dollar | superseded | [clm_23AC4E42292A](/claim/clm_23AC4E42292A.md) - 2021-02-01 to 2022-01-31 | operating_income | 548,000,000 United States dollar | superseded | [clm_B0CD838E4CC5](/claim/clm_B0CD838E4CC5.md) - 2021-02-01 to 2022-01-31 | net_income | 1,444,000,000 United States dollar | superseded | [clm_B385F9E2FBF1](/claim/clm_B385F9E2FBF1.md) - 2021-03-15 to 2021-05-27 | shares_outstanding | 921,000,000 shares | superseded | [clm_27791AA84F9A](/claim/clm_27791AA84F9A.md) - 2021-04-30 to 2021-07-31 | total_assets | 64,885,000,000 United States dollar | superseded | [clm_434A1CF0D700](/claim/clm_434A1CF0D700.md) - 2021-04-30 to 2021-07-31 | quarterly_operating_income | 354,000,000 United States dollar | superseded | [clm_4BE0C07B2F7A](/claim/clm_4BE0C07B2F7A.md) - 2021-04-30 to 2021-07-31 | cash_and_equivalents | 8,544,000,000 United States dollar | superseded | [clm_5FA46B539A1D](/claim/clm_5FA46B539A1D.md) - 2021-04-30 to 2021-07-31 | quarterly_research_and_development | 951,000,000 United States dollar | superseded | [clm_990467F27A27](/claim/clm_990467F27A27.md) - 2021-04-30 to 2021-07-31 | quarterly_net_income | 469,000,000 United States dollar | superseded | [clm_B4810598E505](/claim/clm_B4810598E505.md) - 2021-04-30 to 2021-07-31 | total_equity | 42,567,000,000 United States dollar | superseded | [clm_C57AF9FBB682](/claim/clm_C57AF9FBB682.md) - 2021-04-30 to 2021-07-31 | quarterly_revenue | 5,963,000,000 United States dollar | superseded | [clm_FD1B82A3C094](/claim/clm_FD1B82A3C094.md) - 2021-05-27 to 2021-08-25 | shares_outstanding | 926,000,000 shares | superseded | [clm_EBB941149301](/claim/clm_EBB941149301.md) - 2021-07-31 to 2021-10-31 | quarterly_research_and_development | 1,020,000,000 United States dollar | superseded | [clm_138D719F2B14](/claim/clm_138D719F2B14.md) - 2021-07-31 to 2021-10-31 | total_equity | 55,520,000,000 United States dollar | superseded | [clm_355229E656C0](/claim/clm_355229E656C0.md) - 2021-07-31 to 2021-10-31 | cash_and_equivalents | 6,299,000,000 United States dollar | superseded | [clm_3CB364D31C13](/claim/clm_3CB364D31C13.md) - 2021-07-31 to 2021-10-31 | quarterly_revenue | 6,340,000,000 United States dollar | superseded | [clm_55D63A877B04](/claim/clm_55D63A877B04.md) - 2021-07-31 to 2021-10-31 | quarterly_net_income | 535,000,000 United States dollar | superseded | [clm_D01B87AD36C6](/claim/clm_D01B87AD36C6.md) - 2021-07-31 to 2021-10-31 | total_assets | 88,658,000,000 United States dollar | superseded | [clm_D1A3F174C165](/claim/clm_D1A3F174C165.md) - 2021-07-31 to 2021-10-31 | quarterly_operating_income | 332,000,000 United States dollar | superseded | [clm_DFECDA6FFCD4](/claim/clm_DFECDA6FFCD4.md) - 2021-08-25 to 2021-11-30 | shares_outstanding | 979,000,000 shares | superseded | [clm_B402F2608B80](/claim/clm_B402F2608B80.md) - 2021-10-31 to 2022-01-31 | total_equity | 57,054,000,000 United States dollar | superseded | [clm_06B8AD52A35F](/claim/clm_06B8AD52A35F.md) - 2021-10-31 to 2022-04-30 | quarterly_operating_income | 38,000,000 United States dollar | superseded | [clm_257B07277CD9](/claim/clm_257B07277CD9.md) - 2021-10-31 to 2022-04-30 | quarterly_net_income | 468,000,000 United States dollar | superseded | [clm_55588A4EBD80](/claim/clm_55588A4EBD80.md) - 2021-10-31 to 2022-04-30 | quarterly_research_and_development | 1,203,000,000 United States dollar | superseded | [clm_63BD383F3795](/claim/clm_63BD383F3795.md) - 2021-10-31 to 2022-04-30 | quarterly_revenue | 6,863,000,000 United States dollar | superseded | [clm_69B22034E7EC](/claim/clm_69B22034E7EC.md) - 2021-10-31 to 2022-01-31 | total_assets | 87,436,000,000 United States dollar | superseded | [clm_C6AF9AD5DAAA](/claim/clm_C6AF9AD5DAAA.md) - 2021-10-31 to 2022-01-31 | cash_and_equivalents | 4,753,000,000 United States dollar | superseded | [clm_E2C86C7442FA](/claim/clm_E2C86C7442FA.md) - 2021-11-30 to 2022-03-01 | shares_outstanding | 985,000,000 shares | superseded | [clm_FA9B853BFD5B](/claim/clm_FA9B853BFD5B.md) ## 2022 - 2022-01-31 to 2022-02-01 | revenue | 26,492,000,000 United States dollar | superseded | [clm_11B7DEFB7F09](/claim/clm_11B7DEFB7F09.md) - 2022-01-31 to 2023-01-31 | research_and_development | 4,465,000,000 United States dollar | superseded | [clm_2294BBA2FBF0](/claim/clm_2294BBA2FBF0.md) - 2022-01-31 to 2022-04-30 | total_assets | 95,209,000,000 United States dollar | superseded | [clm_277E0D544455](/claim/clm_277E0D544455.md) - 2022-01-31 to 2022-02-01 | net_income | 1,444,000,000 United States dollar | superseded | [clm_3FB8274B1D11](/claim/clm_3FB8274B1D11.md) - 2022-01-31 to 2022-04-30 | total_equity | 58,131,000,000 United States dollar | superseded | [clm_58815BFC317C](/claim/clm_58815BFC317C.md) - 2022-01-31 to 2022-02-01 | operating_income | 548,000,000 United States dollar | superseded | [clm_B915C5E0188B](/claim/clm_B915C5E0188B.md) - 2022-01-31 to 2022-04-30 | cash_and_equivalents | 5,464,000,000 United States dollar | superseded | [clm_E5560E76AB91](/claim/clm_E5560E76AB91.md) - 2022-02-01 to 2023-01-31 | operating_income | 1,030,000,000 United States dollar | superseded | [clm_94365C59EB7B](/claim/clm_94365C59EB7B.md) - 2022-02-01 to 2023-01-31 | net_income | 208,000,000 United States dollar | superseded | [clm_C48263269A3D](/claim/clm_C48263269A3D.md) - 2022-02-01 to 2023-01-31 | revenue | 31,352,000,000 United States dollar | superseded | [clm_CC52BB88A8B5](/claim/clm_CC52BB88A8B5.md) - 2022-03-01 to 2022-05-31 | shares_outstanding | 990,000,000 shares | superseded | [clm_143A380C373D](/claim/clm_143A380C373D.md) - 2022-03-02 | model_release | Salesforce/codet5-base | valid | [clm_0FBA439C5B8B](/claim/clm_0FBA439C5B8B.md) - 2022-03-02 | model_release | Salesforce/mixqg-base | valid | [clm_1B7833273E76](/claim/clm_1B7833273E76.md) - 2022-03-02 | model_release | Salesforce/bart-large-xsum-samsum | valid | [clm_2BC72672E95A](/claim/clm_2BC72672E95A.md) - 2022-03-02 | model_release | Salesforce/qaconv-unifiedqa-t5-base | valid | [clm_2D952AF5151A](/claim/clm_2D952AF5151A.md) - 2022-03-02 | model_release | Salesforce/codet5-base-multi-sum | valid | [clm_4F28E0B1A755](/claim/clm_4F28E0B1A755.md) - 2022-03-02 | model_release | Salesforce/mixqg-large | valid | [clm_5ED2EB4F561C](/claim/clm_5ED2EB4F561C.md) - 2022-03-02 | model_release | Salesforce/qaconv-roberta-large-squad2 | valid | [clm_6A1FB3A268DB](/claim/clm_6A1FB3A268DB.md) - 2022-03-02 | model_release | Salesforce/mixqg-3b | valid | [clm_7BD86093E32E](/claim/clm_7BD86093E32E.md) - 2022-03-02 | model_release | Salesforce/ctrl | valid | [clm_820F60398DFA](/claim/clm_820F60398DFA.md) - 2022-03-02 | model_release | Salesforce/qaconv-bert-large-uncased-whole-word-masking-squad2 | valid | [clm_85D28C31EA26](/claim/clm_85D28C31EA26.md) - 2022-03-02 | model_release | Salesforce/qaconv-unifiedqa-t5-large | valid | [clm_AE6659A52584](/claim/clm_AE6659A52584.md) - 2022-03-02 | model_release | Salesforce/grappa_large_jnt | valid | [clm_B5F5D8502DAC](/claim/clm_B5F5D8502DAC.md) - 2022-03-02 | model_release | Salesforce/cods-bart-large-xsum-samsum | valid | [clm_C69DD26678C2](/claim/clm_C69DD26678C2.md) - 2022-03-02 | model_release | Salesforce/qaconv-unifiedqa-t5-3b | valid | [clm_DE17924A7AE6](/claim/clm_DE17924A7AE6.md) - 2022-03-02 | model_release | Salesforce/codet5-small | valid | [clm_F210825DDB2D](/claim/clm_F210825DDB2D.md) - 2022-04-11 | model_release | Salesforce/codegen-350M-multi | valid | [clm_798C445F0A28](/claim/clm_798C445F0A28.md) - 2022-04-11 | model_release | Salesforce/codegen-350M-nl | valid | [clm_AC2EB36E13B4](/claim/clm_AC2EB36E13B4.md) - 2022-04-11 | model_release | Salesforce/codegen-2B-multi | valid | [clm_B2C8C8284F19](/claim/clm_B2C8C8284F19.md) - 2022-04-11 | model_release | Salesforce/codegen-350M-mono | valid | [clm_C1EACB49C51C](/claim/clm_C1EACB49C51C.md) - 2022-04-11 | model_release | Salesforce/codegen-2B-mono | valid | [clm_E39D595662E3](/claim/clm_E39D595662E3.md) - 2022-04-11 | model_release | Salesforce/codegen-2B-nl | valid | [clm_F0E04A502FC9](/claim/clm_F0E04A502FC9.md) - 2022-04-13 | model_release | Salesforce/codegen-16B-nl | valid | [clm_17F9B65B8AFC](/claim/clm_17F9B65B8AFC.md) - 2022-04-13 | model_release | Salesforce/codegen-16B-multi | valid | [clm_49BD539B2F25](/claim/clm_49BD539B2F25.md) - 2022-04-13 | model_release | Salesforce/codegen-6B-mono | valid | [clm_53A346DA4956](/claim/clm_53A346DA4956.md) - 2022-04-13 | model_release | Salesforce/codegen-16B-mono | valid | [clm_5EDB43F0D55B](/claim/clm_5EDB43F0D55B.md) - 2022-04-13 | model_release | Salesforce/codegen-6B-multi | valid | [clm_8F3FD605CEA1](/claim/clm_8F3FD605CEA1.md) - 2022-04-13 | model_release | Salesforce/codegen-6B-nl | valid | [clm_E2D6108D156E](/claim/clm_E2D6108D156E.md) - 2022-04-30 to 2022-07-31 | quarterly_revenue | 7,411,000,000 United States dollar | superseded | [clm_04A9BBFA7056](/claim/clm_04A9BBFA7056.md) - 2022-04-30 to 2022-07-31 | quarterly_research_and_development | 1,318,000,000 United States dollar | superseded | [clm_4154B14364E3](/claim/clm_4154B14364E3.md) - 2022-04-30 to 2022-07-31 | cash_and_equivalents | 6,859,000,000 United States dollar | superseded | [clm_5DF60C01CB20](/claim/clm_5DF60C01CB20.md) - 2022-04-30 to 2022-07-31 | total_assets | 93,022,000,000 United States dollar | superseded | [clm_62383091ADBC](/claim/clm_62383091ADBC.md) - 2022-04-30 to 2022-07-31 | quarterly_operating_income | 20,000,000 United States dollar | superseded | [clm_705FB57FCDDC](/claim/clm_705FB57FCDDC.md) - 2022-04-30 to 2022-07-31 | total_equity | 58,876,000,000 United States dollar | superseded | [clm_72801285A9CE](/claim/clm_72801285A9CE.md) - 2022-04-30 to 2022-07-31 | quarterly_net_income | 28,000,000 United States dollar | superseded | [clm_AFC3EE106A3D](/claim/clm_AFC3EE106A3D.md) - 2022-05-31 to 2022-08-24 | shares_outstanding | 995,000,000 shares | superseded | [clm_B44BD403CBC5](/claim/clm_B44BD403CBC5.md) - 2022-07-06 | model_release | Salesforce/codet5-large | valid | [clm_326A1F9546F1](/claim/clm_326A1F9546F1.md) - 2022-07-06 | model_release | Salesforce/codet5-large-ntp-py | valid | [clm_68DBDDA2FBF6](/claim/clm_68DBDDA2FBF6.md) - 2022-07-31 to 2022-10-31 | total_equity | 60,098,000,000 United States dollar | superseded | [clm_0E63936C94DF](/claim/clm_0E63936C94DF.md) - 2022-07-31 to 2022-10-31 | cash_and_equivalents | 6,931,000,000 United States dollar | superseded | [clm_10EDD7774845](/claim/clm_10EDD7774845.md) - 2022-07-31 to 2022-10-31 | quarterly_net_income | 68,000,000 United States dollar | superseded | [clm_721F0C7D195C](/claim/clm_721F0C7D195C.md) - 2022-07-31 to 2022-10-31 | total_assets | 94,148,000,000 United States dollar | superseded | [clm_7E21B633AC16](/claim/clm_7E21B633AC16.md) - 2022-07-31 to 2022-10-31 | quarterly_research_and_development | 1,329,000,000 United States dollar | superseded | [clm_83DF31C2C6AF](/claim/clm_83DF31C2C6AF.md) - 2022-07-31 to 2022-10-31 | quarterly_operating_income | 193,000,000 United States dollar | superseded | [clm_E0141A759A0D](/claim/clm_E0141A759A0D.md) - 2022-07-31 to 2022-10-31 | quarterly_revenue | 7,720,000,000 United States dollar | superseded | [clm_ED994486C674](/claim/clm_ED994486C674.md) - 2022-08-24 to 2022-11-29 | shares_outstanding | 1,000,000,000 shares | superseded | [clm_25DBA264AB26](/claim/clm_25DBA264AB26.md) - 2022-10-14 | model_release | Salesforce/discord_qg | valid | [clm_A7F704DED98D](/claim/clm_A7F704DED98D.md) - 2022-10-14 | model_release | Salesforce/qa_consolidation | valid | [clm_B11CB3E909DD](/claim/clm_B11CB3E909DD.md) - 2022-10-17 | model_release | Salesforce/discord_qa | valid | [clm_8D71C5C60C89](/claim/clm_8D71C5C60C89.md) - 2022-10-31 to 2023-01-31 | total_assets | 91,884,000,000 United States dollar | superseded | [clm_007D4E3B1107](/claim/clm_007D4E3B1107.md) - 2022-10-31 to 2023-04-30 | quarterly_net_income | 210,000,000 United States dollar | superseded | [clm_0ED7EACA4A15](/claim/clm_0ED7EACA4A15.md) - 2022-10-31 to 2023-01-31 | cash_and_equivalents | 6,076,000,000 United States dollar | superseded | [clm_1C3EA9868437](/claim/clm_1C3EA9868437.md) - 2022-10-31 to 2023-04-30 | quarterly_revenue | 7,837,000,000 United States dollar | superseded | [clm_7721053EA086](/claim/clm_7721053EA086.md) - 2022-10-31 to 2023-01-31 | total_equity | 59,351,000,000 United States dollar | superseded | [clm_870676968F9C](/claim/clm_870676968F9C.md) - 2022-10-31 to 2023-04-30 | quarterly_operating_income | 460,000,000 United States dollar | superseded | [clm_C05FAD2D0017](/claim/clm_C05FAD2D0017.md) - 2022-10-31 to 2023-04-30 | quarterly_research_and_development | 1,280,000,000 United States dollar | superseded | [clm_E90FC0F91E3D](/claim/clm_E90FC0F91E3D.md) - 2022-11-28 | model_release | Salesforce/BLIP | valid | [clm_2D16C32D1AF7](/claim/clm_2D16C32D1AF7.md) - 2022-11-29 to 2023-03-07 | shares_outstanding | 1,000,000,000 shares | superseded | [clm_D92D1799320E](/claim/clm_D92D1799320E.md) - 2022-12-12 | model_release | Salesforce/blip-vqa-base | valid | [clm_48D0E4F78073](/claim/clm_48D0E4F78073.md) - 2022-12-12 | model_release | Salesforce/blip-image-captioning-base | valid | [clm_6ED2406E959F](/claim/clm_6ED2406E959F.md) - 2022-12-12 | model_release | Salesforce/blip-itm-base-coco | valid | [clm_D9C8899087FD](/claim/clm_D9C8899087FD.md) - 2022-12-13 | model_release | Salesforce/blip-itm-large-flickr | valid | [clm_025E5C0A4DC5](/claim/clm_025E5C0A4DC5.md) - 2022-12-13 | model_release | Salesforce/blip-itm-large-coco | valid | [clm_5DD1E4182D52](/claim/clm_5DD1E4182D52.md) - 2022-12-13 | model_release | Salesforce/blip-image-captioning-large | valid | [clm_5F26D1095084](/claim/clm_5F26D1095084.md) - 2022-12-13 | model_release | Salesforce/blip-vqa-capfilt-large | valid | [clm_929F0BEB4346](/claim/clm_929F0BEB4346.md) - 2022-12-13 | model_release | Salesforce/blip-itm-base-flickr | valid | [clm_C8F3236ACA01](/claim/clm_C8F3236ACA01.md) ## 2023 - 2023-01-31 to 2023-04-30 | cash_and_equivalents | 7,016,000,000 United States dollar | superseded | [clm_277578FDDF34](/claim/clm_277578FDDF34.md) - 2023-01-31 to 2023-04-30 | total_assets | 98,849,000,000 United States dollar | superseded | [clm_291F4294953A](/claim/clm_291F4294953A.md) - 2023-01-31 to 2024-01-31 | research_and_development | 5,055,000,000 United States dollar | superseded | [clm_3C902DAB4A7B](/claim/clm_3C902DAB4A7B.md) - 2023-01-31 to 2023-04-30 | total_equity | 58,359,000,000 United States dollar | superseded | [clm_B50453523555](/claim/clm_B50453523555.md) - 2023-01-31 to 2023-02-01 | revenue | 31,352,000,000 United States dollar | superseded | [clm_D64DBD244536](/claim/clm_D64DBD244536.md) - 2023-01-31 to 2023-02-01 | net_income | 208,000,000 United States dollar | superseded | [clm_D765AACFCF28](/claim/clm_D765AACFCF28.md) - 2023-01-31 to 2023-02-01 | operating_income | 1,030,000,000 United States dollar | superseded | [clm_EDBF9338E47B](/claim/clm_EDBF9338E47B.md) - 2023-02-01 to 2024-01-31 | revenue | 34,857,000,000 United States dollar | superseded | [clm_439E7AF5C0C7](/claim/clm_439E7AF5C0C7.md) - 2023-02-01 to 2024-01-31 | net_income | 4,136,000,000 United States dollar | superseded | [clm_730F77D2BF98](/claim/clm_730F77D2BF98.md) - 2023-02-01 to 2024-01-31 | operating_income | 5,011,000,000 United States dollar | superseded | [clm_B19BE5CFD934](/claim/clm_B19BE5CFD934.md) - 2023-02-06 | model_release | Salesforce/blip2-flan-t5-xl | valid | [clm_382E9F9BF512](/claim/clm_382E9F9BF512.md) - 2023-02-06 | model_release | Salesforce/blip2-opt-2.7b | valid | [clm_996E81C36719](/claim/clm_996E81C36719.md) - 2023-02-07 | model_release | Salesforce/blip2-opt-6.7b-coco | valid | [clm_00F84BDD50D9](/claim/clm_00F84BDD50D9.md) - 2023-02-07 | model_release | Salesforce/blip2-opt-2.7b-coco | valid | [clm_4EACA4E4DFEB](/claim/clm_4EACA4E4DFEB.md) - 2023-02-07 | model_release | Salesforce/blip2-opt-6.7b | valid | [clm_65A1906B42D0](/claim/clm_65A1906B42D0.md) - 2023-02-07 | model_release | Salesforce/blip2-flan-t5-xl-coco | valid | [clm_CD038CCD8CF2](/claim/clm_CD038CCD8CF2.md) - 2023-02-09 | model_release | Salesforce/blip2-flan-t5-xxl | valid | [clm_B56E8E9690B6](/claim/clm_B56E8E9690B6.md) - 2023-03-07 to 2023-05-30 | shares_outstanding | 1,000,000,000 shares | superseded | [clm_30679408BBA6](/claim/clm_30679408BBA6.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-sum-php | valid | [clm_0F0A5EAF6CFF](/claim/clm_0F0A5EAF6CFF.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-clone | valid | [clm_30B0858BA7AD](/claim/clm_30B0858BA7AD.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-translate-java-cs | valid | [clm_7C64D2D7BEA9](/claim/clm_7C64D2D7BEA9.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-refine-medium | valid | [clm_7E4932BAE352](/claim/clm_7E4932BAE352.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-concode | valid | [clm_91E1CEE5BA7A](/claim/clm_91E1CEE5BA7A.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-sum-ruby | valid | [clm_92E88843CDC4](/claim/clm_92E88843CDC4.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-sum-java | valid | [clm_9FC3733A58EB](/claim/clm_9FC3733A58EB.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-translate-cs-java | valid | [clm_B08EB90C9FB7](/claim/clm_B08EB90C9FB7.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-sum-python | valid | [clm_B44EBA64D6A7](/claim/clm_B44EBA64D6A7.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-refine-small | valid | [clm_CCC36B9D6E5F](/claim/clm_CCC36B9D6E5F.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-sum-javascript | valid | [clm_D4165BABCCB9](/claim/clm_D4165BABCCB9.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-sum-go | valid | [clm_DE334F1179F3](/claim/clm_DE334F1179F3.md) - 2023-04-20 | model_release | Salesforce/codet5-base-codexglue-defect | valid | [clm_F573C35E7EBC](/claim/clm_F573C35E7EBC.md) - 2023-04-25 | model_release | Salesforce/codegen2-1B_P | valid | [clm_42CA098AE792](/claim/clm_42CA098AE792.md) - 2023-04-25 | model_release | Salesforce/codegen2-3_7B_P | valid | [clm_9736D8DC66E7](/claim/clm_9736D8DC66E7.md) - 2023-04-26 | model_release | Salesforce/codegen2-16B_P | valid | [clm_A2C6F6FBBCD1](/claim/clm_A2C6F6FBBCD1.md) - 2023-04-26 | model_release | Salesforce/codegen2-7B_P | valid | [clm_AE048409F3C3](/claim/clm_AE048409F3C3.md) - 2023-04-27 | model_release | Salesforce/safety-flan-t5-base | valid | [clm_AB4E98C127CF](/claim/clm_AB4E98C127CF.md) - 2023-04-27 | model_release | Salesforce/safety-flan-t5-small | valid | [clm_FCB7964824A9](/claim/clm_FCB7964824A9.md) - 2023-04-30 to 2023-07-31 | quarterly_operating_income | 412,000,000 United States dollar | superseded | [clm_4AB0246352B7](/claim/clm_4AB0246352B7.md) - 2023-04-30 to 2023-07-31 | total_assets | 93,541,000,000 United States dollar | superseded | [clm_5F9F812EB172](/claim/clm_5F9F812EB172.md) - 2023-04-30 to 2023-07-31 | quarterly_research_and_development | 1,207,000,000 United States dollar | superseded | [clm_61F2AF4CFD8D](/claim/clm_61F2AF4CFD8D.md) - 2023-04-30 to 2023-07-31 | total_equity | 57,412,000,000 United States dollar | superseded | [clm_8470BD93ABC3](/claim/clm_8470BD93ABC3.md) - 2023-04-30 to 2023-07-31 | quarterly_net_income | 199,000,000 United States dollar | superseded | [clm_D0A0AF83110F](/claim/clm_D0A0AF83110F.md) - 2023-04-30 to 2023-07-31 | cash_and_equivalents | 9,155,000,000 United States dollar | superseded | [clm_F822080667DE](/claim/clm_F822080667DE.md) - 2023-04-30 to 2023-07-31 | quarterly_revenue | 8,247,000,000 United States dollar | superseded | [clm_FBA35A5F6F52](/claim/clm_FBA35A5F6F52.md) - 2023-05-13 | model_release | Salesforce/codet5p-770m | valid | [clm_7D174D06AFB7](/claim/clm_7D174D06AFB7.md) - 2023-05-13 | model_release | Salesforce/codet5p-220m | valid | [clm_C5F2C8485F74](/claim/clm_C5F2C8485F74.md) - 2023-05-15 | model_release | Salesforce/codet5p-220m-py | valid | [clm_3123E5CF24B7](/claim/clm_3123E5CF24B7.md) - 2023-05-15 | model_release | Salesforce/codet5p-770m-py | valid | [clm_434D5F3B00A9](/claim/clm_434D5F3B00A9.md) - 2023-05-16 | model_release | Salesforce/instructcodet5p-16b | valid | [clm_B8B09C5BE11E](/claim/clm_B8B09C5BE11E.md) - 2023-05-17 | model_release | Salesforce/bic_simple_edit_id | valid | [clm_12B928F4B1E1](/claim/clm_12B928F4B1E1.md) - 2023-05-17 | model_release | Salesforce/bart-large-swipe | valid | [clm_280AAD3B4ABB](/claim/clm_280AAD3B4ABB.md) - 2023-05-17 | model_release | Salesforce/codet5p-2b | valid | [clm_2A97C1DF9C85](/claim/clm_2A97C1DF9C85.md) - 2023-05-17 | model_release | Salesforce/codet5p-16b | valid | [clm_71C25605E0E6](/claim/clm_71C25605E0E6.md) - 2023-05-17 | model_release | Salesforce/bart-large-swipe-clean | valid | [clm_7F2B1FB275C7](/claim/clm_7F2B1FB275C7.md) - 2023-05-17 | model_release | Salesforce/codet5p-6b | valid | [clm_C2B05D945A92](/claim/clm_C2B05D945A92.md) - 2023-05-22 | model_release | Salesforce/instructblip-vicuna-7b | valid | [clm_7629EB444ED8](/claim/clm_7629EB444ED8.md) - 2023-05-28 | model_release | Salesforce/instructblip-flan-t5-xl | valid | [clm_1D04D29DF7E9](/claim/clm_1D04D29DF7E9.md) - 2023-05-30 to 2023-08-28 | shares_outstanding | 974,000,000 shares | superseded | [clm_70E0C7EF25DA](/claim/clm_70E0C7EF25DA.md) - 2023-06-03 | model_release | Salesforce/instructblip-flan-t5-xxl | valid | [clm_0E461735E250](/claim/clm_0E461735E250.md) - 2023-06-03 | model_release | Salesforce/instructblip-vicuna-13b | valid | [clm_16AC0D90B50D](/claim/clm_16AC0D90B50D.md) - 2023-06-28 | model_release | Salesforce/xgen-7b-4k-base | valid | [clm_A948E34A8A97](/claim/clm_A948E34A8A97.md) - 2023-06-28 | model_release | Salesforce/xgen-7b-8k-base | valid | [clm_DCF1EB64E88F](/claim/clm_DCF1EB64E88F.md) - 2023-06-28 | model_release | Salesforce/xgen-7b-8k-inst | valid | [clm_F39735E77E7E](/claim/clm_F39735E77E7E.md) - 2023-07-06 | model_release | Salesforce/codegen25-7b-mono_P | valid | [clm_28CF52A41076](/claim/clm_28CF52A41076.md) - 2023-07-06 | model_release | Salesforce/codegen25-7b-multi_P | valid | [clm_403EAFD67013](/claim/clm_403EAFD67013.md) - 2023-07-06 | model_release | Salesforce/codegen25-7b-instruct_P | valid | [clm_CAAC2ED23BCB](/claim/clm_CAAC2ED23BCB.md) - 2023-07-18 | model_release | Salesforce/codet5p-110m-embedding | valid | [clm_41D85BC70CEF](/claim/clm_41D85BC70CEF.md) - 2023-07-19 | model_release | Salesforce/codet5p-220m-bimodal | valid | [clm_7F1D77289E78](/claim/clm_7F1D77289E78.md) - 2023-07-21 | model_release | Salesforce/qmsum-socratic-books-30M | valid | [clm_BEF53ADA0C9B](/claim/clm_BEF53ADA0C9B.md) - 2023-07-21 | model_release | Salesforce/socratic-pretraining-qmsum | valid | [clm_FC352B0E5DBB](/claim/clm_FC352B0E5DBB.md) - 2023-07-24 | model_release | Salesforce/squality-socratic-books-30M | valid | [clm_2D1E65B024E2](/claim/clm_2D1E65B024E2.md) - 2023-07-24 | model_release | Salesforce/socratic-books-30M | valid | [clm_BCBEE5560281](/claim/clm_BCBEE5560281.md) - 2023-07-31 to 2023-10-31 | cash_and_equivalents | 6,772,000,000 United States dollar | superseded | [clm_12038FF6AEC7](/claim/clm_12038FF6AEC7.md) - 2023-07-31 to 2023-10-31 | total_equity | 58,082,000,000 United States dollar | superseded | [clm_416EF742C8DC](/claim/clm_416EF742C8DC.md) - 2023-07-31 to 2023-10-31 | quarterly_revenue | 8,603,000,000 United States dollar | superseded | [clm_75E87843C0C0](/claim/clm_75E87843C0C0.md) - 2023-07-31 to 2023-10-31 | quarterly_net_income | 1,267,000,000 United States dollar | superseded | [clm_89CC65EEFD1D](/claim/clm_89CC65EEFD1D.md) - 2023-07-31 to 2023-10-31 | quarterly_research_and_development | 1,220,000,000 United States dollar | superseded | [clm_A5C871E41235](/claim/clm_A5C871E41235.md) - 2023-07-31 to 2023-10-31 | total_assets | 92,447,000,000 United States dollar | superseded | [clm_D2E0848328CC](/claim/clm_D2E0848328CC.md) - 2023-07-31 to 2023-10-31 | quarterly_operating_income | 1,476,000,000 United States dollar | superseded | [clm_F74FD197B040](/claim/clm_F74FD197B040.md) - 2023-08-18 | model_release | Salesforce/dialogstudio-t5-base-v1.0 | valid | [clm_3D1F88D76B3D](/claim/clm_3D1F88D76B3D.md) - 2023-08-18 | model_release | Salesforce/dialogstudio-t5-large-v1.0 | valid | [clm_AB466C0E9547](/claim/clm_AB466C0E9547.md) - 2023-08-23 | model_release | Salesforce/blip2-itm-vit-g | valid | [clm_130DA11B8D07](/claim/clm_130DA11B8D07.md) - 2023-08-23 | model_release | Salesforce/blip2-itm-vit-g-coco | valid | [clm_3C893B488A6F](/claim/clm_3C893B488A6F.md) - 2023-08-28 to 2023-11-27 | shares_outstanding | 973,000,000 shares | superseded | [clm_C38DCECD4E03](/claim/clm_C38DCECD4E03.md) - 2023-09-05 | model_release | Salesforce/dialogstudio-t5-3b-v1.0 | valid | [clm_84334B67E93B](/claim/clm_84334B67E93B.md) - 2023-10-31 to 2024-04-30 | quarterly_revenue | 8,720,000,000 United States dollar | superseded | [clm_325242F566A9](/claim/clm_325242F566A9.md) - 2023-10-31 to 2024-01-31 | total_equity | 58,090,000,000 United States dollar | superseded | [clm_7D236DFBC525](/claim/clm_7D236DFBC525.md) - 2023-10-31 to 2024-04-30 | quarterly_net_income | 1,224,000,000 United States dollar | superseded | [clm_84D8174373ED](/claim/clm_84D8174373ED.md) - 2023-10-31 to 2024-01-31 | cash_and_equivalents | 6,453,000,000 United States dollar | superseded | [clm_89BEB4EF78BA](/claim/clm_89BEB4EF78BA.md) - 2023-10-31 to 2024-04-30 | quarterly_operating_income | 1,501,000,000 United States dollar | superseded | [clm_AD2C218BF8F2](/claim/clm_AD2C218BF8F2.md) - 2023-10-31 to 2024-04-30 | quarterly_research_and_development | 1,204,000,000 United States dollar | superseded | [clm_AF57EFA735F2](/claim/clm_AF57EFA735F2.md) - 2023-10-31 to 2024-01-31 | total_assets | 91,022,000,000 United States dollar | superseded | [clm_FCDFD2C505AF](/claim/clm_FCDFD2C505AF.md) - 2023-11-27 to 2024-02-29 | shares_outstanding | 968,000,000 shares | superseded | [clm_BF050ACA8D37](/claim/clm_BF050ACA8D37.md) ## 2024 - 2024-01-24 | model_release | Salesforce/SFR-Embedding-Mistral | valid | [clm_BF006FE0D3D9](/claim/clm_BF006FE0D3D9.md) - 2024-01-31 to 2024-04-30 | cash_and_equivalents | 8,472,000,000 United States dollar | superseded | [clm_16EE1A68647B](/claim/clm_16EE1A68647B.md) - 2024-01-31 to 2024-02-01 | operating_income | 5,011,000,000 United States dollar | superseded | [clm_4401F660A046](/claim/clm_4401F660A046.md) - 2024-01-31 to 2025-01-31 | research_and_development | 4,906,000,000 United States dollar | superseded | [clm_4E5E0E751F0C](/claim/clm_4E5E0E751F0C.md) - 2024-01-31 to 2024-04-30 | total_equity | 59,646,000,000 United States dollar | superseded | [clm_B61E26984193](/claim/clm_B61E26984193.md) - 2024-01-31 to 2024-02-01 | revenue | 34,857,000,000 United States dollar | superseded | [clm_D258D5E93745](/claim/clm_D258D5E93745.md) - 2024-01-31 to 2024-04-30 | total_assets | 99,823,000,000 United States dollar | superseded | [clm_E0987B400598](/claim/clm_E0987B400598.md) - 2024-01-31 to 2024-02-01 | net_income | 4,136,000,000 United States dollar | superseded | [clm_E46FFE0F21B9](/claim/clm_E46FFE0F21B9.md) - 2024-02-01 to 2025-01-31 | revenue | 37,895,000,000 United States dollar | superseded | [clm_820B315E2D45](/claim/clm_820B315E2D45.md) - 2024-02-01 to 2025-01-31 | net_income | 6,197,000,000 United States dollar | superseded | [clm_842867E4B0B3](/claim/clm_842867E4B0B3.md) - 2024-02-01 to 2025-01-31 | operating_income | 7,205,000,000 United States dollar | superseded | [clm_CC5B4FFBDB12](/claim/clm_CC5B4FFBDB12.md) - 2024-02-11 | model_release | Salesforce/moirai-1.0-R-small | valid | [clm_468AC6CB4397](/claim/clm_468AC6CB4397.md) - 2024-02-11 | model_release | Salesforce/moirai-1.0-R-large | valid | [clm_84B57C1A1A96](/claim/clm_84B57C1A1A96.md) - 2024-02-11 | model_release | Salesforce/moirai-1.0-R-base | valid | [clm_915E946507D3](/claim/clm_915E946507D3.md) - 2024-02-29 to 2024-05-24 | shares_outstanding | 970,000,000 shares | superseded | [clm_FB10EEB86E1E](/claim/clm_FB10EEB86E1E.md) - 2024-03-18 | model_release | Salesforce/xLAM-v0.1-r | valid | [clm_3F4DA2D93D61](/claim/clm_3F4DA2D93D61.md) - 2024-04-30 to 2024-07-31 | quarterly_operating_income | 1,709,000,000 United States dollar | superseded | [clm_0D4A34CDF0D5](/claim/clm_0D4A34CDF0D5.md) - 2024-04-30 to 2024-07-31 | quarterly_revenue | 9,133,000,000 United States dollar | superseded | [clm_1CAC5957C2CF](/claim/clm_1CAC5957C2CF.md) - 2024-04-30 to 2024-07-31 | cash_and_equivalents | 9,958,000,000 United States dollar | superseded | [clm_78AF38BCB207](/claim/clm_78AF38BCB207.md) - 2024-04-30 to 2024-07-31 | quarterly_research_and_development | 1,368,000,000 United States dollar | superseded | [clm_9ACF0E018422](/claim/clm_9ACF0E018422.md) - 2024-04-30 to 2024-07-31 | total_equity | 59,683,000,000 United States dollar | superseded | [clm_B9F6BA3EC49F](/claim/clm_B9F6BA3EC49F.md) - 2024-04-30 to 2024-07-31 | total_assets | 96,180,000,000 United States dollar | superseded | [clm_E0D51A15F62B](/claim/clm_E0D51A15F62B.md) - 2024-04-30 to 2024-07-31 | quarterly_net_income | 1,533,000,000 United States dollar | superseded | [clm_FD361A8D5356](/claim/clm_FD361A8D5356.md) - 2024-05-06 | model_release | Salesforce/xgen-mm-phi3-mini-instruct-r-v1 | valid | [clm_C8D40C18C5EB](/claim/clm_C8D40C18C5EB.md) - 2024-05-07 | model_release | Salesforce/xgen-mm-phi3-mini-base-r-v1 | valid | [clm_4744D22A9912](/claim/clm_4744D22A9912.md) - 2024-05-09 | model_release | Salesforce/LLaMA-3-8B-SFR-Iterative-DPO-R | valid | [clm_2B7657B5DA6E](/claim/clm_2B7657B5DA6E.md) - 2024-05-10 | model_release | Salesforce/LLaMA-3-8B-SFR-SFT-R | valid | [clm_2153E1597899](/claim/clm_2153E1597899.md) - 2024-05-14 | model_release | Salesforce/LLaMA-3-8B-SFR-RM-R | valid | [clm_BD55648AD502](/claim/clm_BD55648AD502.md) - 2024-05-24 to 2024-08-23 | shares_outstanding | 969,000,000 shares | superseded | [clm_3A52ECC702FC](/claim/clm_3A52ECC702FC.md) - 2024-06-07 | model_release | Salesforce/LLaMA-3-8B-SFR-Iterative-DPO-Concise-R | valid | [clm_BFA2F1AFF52C](/claim/clm_BFA2F1AFF52C.md) - 2024-06-14 | model_release | Salesforce/moirai-1.1-R-base | valid | [clm_294C5AD63F28](/claim/clm_294C5AD63F28.md) - 2024-06-14 | model_release | Salesforce/SFR-Embedding-2_R | valid | [clm_89AA743EEDC0](/claim/clm_89AA743EEDC0.md) - 2024-06-14 | model_release | Salesforce/moirai-1.1-R-small | valid | [clm_9866DF709CE6](/claim/clm_9866DF709CE6.md) - 2024-06-14 | model_release | Salesforce/moirai-1.1-R-large | valid | [clm_CD4D1DB83A0B](/claim/clm_CD4D1DB83A0B.md) - 2024-07-17 | model_release | Salesforce/xLAM-7b-fc-r | valid | [clm_28E6B8714E66](/claim/clm_28E6B8714E66.md) - 2024-07-17 | model_release | Salesforce/xLAM-1b-fc-r-gguf | valid | [clm_471ADCBE357E](/claim/clm_471ADCBE357E.md) - 2024-07-17 | model_release | Salesforce/xLAM-1b-fc-r | valid | [clm_D1B1EB392B62](/claim/clm_D1B1EB392B62.md) - 2024-07-17 | model_release | Salesforce/xLAM-7b-fc-r-gguf | valid | [clm_E6189D815441](/claim/clm_E6189D815441.md) - 2024-07-31 to 2024-10-31 | total_assets | 92,180,000,000 United States dollar | superseded | [clm_5295E8187866](/claim/clm_5295E8187866.md) - 2024-07-31 to 2024-10-31 | quarterly_research_and_development | 1,349,000,000 United States dollar | superseded | [clm_53490A1F39FE](/claim/clm_53490A1F39FE.md) - 2024-07-31 to 2024-10-31 | quarterly_net_income | 1,429,000,000 United States dollar | superseded | [clm_6DF5A5BA6800](/claim/clm_6DF5A5BA6800.md) - 2024-07-31 to 2024-10-31 | quarterly_operating_income | 1,783,000,000 United States dollar | superseded | [clm_72C16700BD23](/claim/clm_72C16700BD23.md) - 2024-07-31 to 2024-10-31 | cash_and_equivalents | 7,682,000,000 United States dollar | superseded | [clm_B518D3254896](/claim/clm_B518D3254896.md) - 2024-07-31 to 2024-10-31 | total_equity | 57,633,000,000 United States dollar | superseded | [clm_D4C5D3AB21CC](/claim/clm_D4C5D3AB21CC.md) - 2024-07-31 to 2024-10-31 | quarterly_revenue | 9,325,000,000 United States dollar | superseded | [clm_FB33D35CB358](/claim/clm_FB33D35CB358.md) - 2024-08-07 | model_release | Salesforce/xgen-mm-phi3-mini-instruct-singleimg-r-v1.5 | valid | [clm_CCCCC82CD3BD](/claim/clm_CCCCC82CD3BD.md) - 2024-08-09 | model_release | Salesforce/xgen-mm-phi3-mini-instruct-interleave-r-v1.5 | valid | [clm_5739A5EAF1F8](/claim/clm_5739A5EAF1F8.md) - 2024-08-09 | model_release | Salesforce/xgen-mm-phi3-mini-instruct-dpo-r-v1.5 | valid | [clm_E10596E3B287](/claim/clm_E10596E3B287.md) - 2024-08-12 | model_release | Salesforce/xgen-mm-phi3-mini-base-r-v1.5 | valid | [clm_1978C9318A1D](/claim/clm_1978C9318A1D.md) - 2024-08-23 to 2024-11-27 | shares_outstanding | 956,000,000 shares | superseded | [clm_181389285863](/claim/clm_181389285863.md) - 2024-08-28 | model_release | Salesforce/xLAM-7b-r | valid | [clm_219C4A254D1D](/claim/clm_219C4A254D1D.md) - 2024-08-28 | model_release | Salesforce/xLAM-8x7b-r | valid | [clm_91B4774F4802](/claim/clm_91B4774F4802.md) - 2024-08-28 | model_release | Salesforce/xLAM-8x22b-r | valid | [clm_B34C1A2143C6](/claim/clm_B34C1A2143C6.md) - 2024-09-03 | partnership | Anthropic Claude in Einstein 1 Studio | valid | [clm_4C092C856A9E](/claim/clm_4C092C856A9E.md) - 2024-10-27 | model_release | Salesforce/llama3-clip-pretrained-mantis-taco-8b | valid | [clm_01E36132D81D](/claim/clm_01E36132D81D.md) - 2024-10-31 to 2025-04-30 | quarterly_operating_income | 1,893,000,000 United States dollar | superseded | [clm_1880E20979B4](/claim/clm_1880E20979B4.md) - 2024-10-31 to 2025-01-31 | cash_and_equivalents | 7,997,000,000 United States dollar | superseded | [clm_408F614F0A61](/claim/clm_408F614F0A61.md) - 2024-10-31 to 2025-04-30 | quarterly_revenue | 9,444,000,000 United States dollar | superseded | [clm_7E1DA9B9F481](/claim/clm_7E1DA9B9F481.md) - 2024-10-31 to 2025-01-31 | total_equity | 58,525,000,000 United States dollar | superseded | [clm_9B2934FCD25F](/claim/clm_9B2934FCD25F.md) - 2024-10-31 to 2025-01-31 | total_assets | 91,395,000,000 United States dollar | superseded | [clm_A4927604FF03](/claim/clm_A4927604FF03.md) - 2024-10-31 to 2025-04-30 | quarterly_research_and_development | 1,356,000,000 United States dollar | superseded | [clm_B03B5D70F51E](/claim/clm_B03B5D70F51E.md) - 2024-10-31 to 2025-04-30 | quarterly_net_income | 1,527,000,000 United States dollar | superseded | [clm_D9B3747AD568](/claim/clm_D9B3747AD568.md) - 2024-11-01 | model_release | Salesforce/moirai-moe-1.0-R-base | valid | [clm_4C3A9F6C1D56](/claim/clm_4C3A9F6C1D56.md) - 2024-11-01 | model_release | Salesforce/moirai-moe-1.0-R-small | valid | [clm_FD5CA19BF02B](/claim/clm_FD5CA19BF02B.md) - 2024-11-05 | model_release | Salesforce/llama3-siglip-mantis-taco-8b | valid | [clm_0FA0066D07D7](/claim/clm_0FA0066D07D7.md) - 2024-11-27 to 2025-02-28 | shares_outstanding | 957,000,000 shares | superseded | [clm_091CFD39083D](/claim/clm_091CFD39083D.md) - 2024-12-04 | model_release | Salesforce/qwen2-siglip-llava-ov-taco-7b | valid | [clm_1A304847D07F](/claim/clm_1A304847D07F.md) - 2024-12-18 | model_release | Salesforce/xgen-mm-vid-phi3-mini-r-v1.5-128tokens-8frames | valid | [clm_F14F50778448](/claim/clm_F14F50778448.md) ## 2025 - 2025-01-15 | model_release | Salesforce/xgen-mm-vid-phi3-mini-r-v1.5-32tokens-8frames | valid | [clm_CD786D17EC79](/claim/clm_CD786D17EC79.md) - 2025-01-16 | model_release | Salesforce/SFR-Embedding-Code-400M_R | valid | [clm_108E6ED1A4A0](/claim/clm_108E6ED1A4A0.md) - 2025-01-17 | model_release | Salesforce/SFR-Embedding-Code-2B_R | valid | [clm_B2473A187590](/claim/clm_B2473A187590.md) - 2025-01-31 to 2026-01-31 | revenue | 37,895,000,000 United States dollar | superseded | [clm_17DCEE04A421](/claim/clm_17DCEE04A421.md) - 2025-01-31 to 2026-01-31 | operating_income | 7,205,000,000 United States dollar | superseded | [clm_2CF039687A40](/claim/clm_2CF039687A40.md) - 2025-01-31 to 2025-04-30 | total_assets | 102,928,000,000 United States dollar | superseded | [clm_31F9E340F3EA](/claim/clm_31F9E340F3EA.md) - 2025-01-31 to 2025-04-30 | cash_and_equivalents | 8,848,000,000 United States dollar | superseded | [clm_5395EC1657E8](/claim/clm_5395EC1657E8.md) - 2025-01-31 to 2026-01-31 | research_and_development | 5,493,000,000 United States dollar | superseded | [clm_866CACC3B9F4](/claim/clm_866CACC3B9F4.md) - 2025-01-31 to 2025-04-30 | total_equity | 61,173,000,000 United States dollar | superseded | [clm_E407EED24265](/claim/clm_E407EED24265.md) - 2025-01-31 to 2026-01-31 | net_income | 6,197,000,000 United States dollar | superseded | [clm_F1E5AEA8CC47](/claim/clm_F1E5AEA8CC47.md) - 2025-02-17 | model_release | Salesforce/cogalign-internvl2_5-mpo-1b | valid | [clm_0560AE61D5BF](/claim/clm_0560AE61D5BF.md) - 2025-02-17 | model_release | Salesforce/cogalign-internvl2_5-mpo-4b | valid | [clm_843877EC9431](/claim/clm_843877EC9431.md) - 2025-02-17 | model_release | Salesforce/cogalign-llava-ov-0_5b | valid | [clm_C91A206BDF91](/claim/clm_C91A206BDF91.md) - 2025-02-28 to 2025-05-22 | shares_outstanding | 961,000,000 shares | superseded | [clm_E5F0F1086986](/claim/clm_E5F0F1086986.md) - 2025-03-21 | president | Robin Washington | valid | [clm_0CA6CD309E76](/claim/clm_0CA6CD309E76.md) - 2025-03-21 | cfo | Robin Washington | valid | [clm_78A137C9D089](/claim/clm_78A137C9D089.md) - 2025-03-21 | coo | Robin Washington | valid | [clm_DB6215755274](/claim/clm_DB6215755274.md) - 2025-03-25 | model_release | Salesforce/Llama-xLAM-2-70b-fc-r | valid | [clm_28DFD5327AC6](/claim/clm_28DFD5327AC6.md) - 2025-03-27 | model_release | Salesforce/xLAM-2-3b-fc-r | valid | [clm_1421BFE07336](/claim/clm_1421BFE07336.md) - 2025-03-27 | model_release | Salesforce/Llama-xLAM-2-8b-fc-r | valid | [clm_3925FDE777A5](/claim/clm_3925FDE777A5.md) - 2025-03-27 | model_release | Salesforce/xLAM-2-1b-fc-r | valid | [clm_660256BA7D72](/claim/clm_660256BA7D72.md) - 2025-03-27 | model_release | Salesforce/xLAM-2-32b-fc-r | valid | [clm_E471D5C57641](/claim/clm_E471D5C57641.md) - 2025-03-28 | model_release | Salesforce/xLAM-2-3b-fc-r-gguf | valid | [clm_471A2FCE7225](/claim/clm_471A2FCE7225.md) - 2025-03-28 | model_release | Salesforce/xLAM-2-1b-fc-r-gguf | valid | [clm_567489CF0F61](/claim/clm_567489CF0F61.md) - 2025-03-28 | model_release | Salesforce/Llama-xLAM-2-8b-fc-r-gguf | valid | [clm_EDB2490C002E](/claim/clm_EDB2490C002E.md) - 2025-04-15 | model_release | Salesforce/WQRM-PRE | valid | [clm_702B3C8BE1DB](/claim/clm_702B3C8BE1DB.md) - 2025-04-15 | model_release | Salesforce/WQRM | valid | [clm_A1D05E79B19C](/claim/clm_A1D05E79B19C.md) - 2025-04-30 to 2025-07-31 | quarterly_revenue | 9,829,000,000 United States dollar | superseded | [clm_265FCA1C462B](/claim/clm_265FCA1C462B.md) - 2025-04-30 to 2025-07-31 | total_assets | 98,610,000,000 United States dollar | superseded | [clm_28CB9E389BD8](/claim/clm_28CB9E389BD8.md) - 2025-04-30 to 2025-07-31 | quarterly_research_and_development | 1,460,000,000 United States dollar | superseded | [clm_458E85D198F3](/claim/clm_458E85D198F3.md) - 2025-04-30 to 2025-07-31 | quarterly_net_income | 1,541,000,000 United States dollar | superseded | [clm_7279E1B07206](/claim/clm_7279E1B07206.md) - 2025-04-30 to 2025-07-31 | cash_and_equivalents | 10,928,000,000 United States dollar | superseded | [clm_7472751F88C5](/claim/clm_7472751F88C5.md) - 2025-04-30 | model_release | Salesforce/xgen-small-r | valid | [clm_788A22BF8E68](/claim/clm_788A22BF8E68.md) - 2025-04-30 to 2025-07-31 | quarterly_operating_income | 1,942,000,000 United States dollar | superseded | [clm_8BCA5E212265](/claim/clm_8BCA5E212265.md) - 2025-04-30 to 2025-07-31 | total_equity | 60,666,000,000 United States dollar | superseded | [clm_8C6DADE58BC5](/claim/clm_8C6DADE58BC5.md) - 2025-05-07 | model_release | Salesforce/E1-Math-1.5B | valid | [clm_108E03663DAA](/claim/clm_108E03663DAA.md) - 2025-05-09 | model_release | Salesforce/xgen-small-4B-base-r | valid | [clm_055343386577](/claim/clm_055343386577.md) - 2025-05-09 | model_release | Salesforce/xgen-small-4B-instruct-r | valid | [clm_291A3E4AABBD](/claim/clm_291A3E4AABBD.md) - 2025-05-09 | model_release | Salesforce/xgen-small-9B-instruct-r | valid | [clm_93AA99658DE1](/claim/clm_93AA99658DE1.md) - 2025-05-09 | model_release | Salesforce/xgen-small-9B-base-r | valid | [clm_A611007AB0FE](/claim/clm_A611007AB0FE.md) - 2025-05-19 | model_release | Salesforce/E1-Code-14B | valid | [clm_CABE3F02F470](/claim/clm_CABE3F02F470.md) - 2025-05-20 | model_release | Salesforce/Elastic-Reasoning | valid | [clm_2DFB02F038FE](/claim/clm_2DFB02F038FE.md) - 2025-05-22 to 2025-08-28 | shares_outstanding | 956,000,000 shares | superseded | [clm_57A3B3AAFB01](/claim/clm_57A3B3AAFB01.md) - 2025-05-25 | model_release | Salesforce/E1-Math-7B | valid | [clm_801EDA4714DC](/claim/clm_801EDA4714DC.md) - 2025-05-30 | model_release | Salesforce/E1-AceReason-14B | valid | [clm_55E3DE763488](/claim/clm_55E3DE763488.md) - 2025-06-24 | model_release | Salesforce/SweRankLLM-Large | valid | [clm_1367EC68CA11](/claim/clm_1367EC68CA11.md) - 2025-06-24 | model_release | Salesforce/SweRankEmbed-Large | valid | [clm_7621ABF134D2](/claim/clm_7621ABF134D2.md) - 2025-06-24 | model_release | Salesforce/SweRankLLM-Small | valid | [clm_888C70D02796](/claim/clm_888C70D02796.md) - 2025-06-24 | model_release | Salesforce/SweRankEmbed-Small | valid | [clm_A1A7D1E9A20E](/claim/clm_A1A7D1E9A20E.md) - 2025-06-26 | model_release | Salesforce/moirai-1.5-llama-kvcache | valid | [clm_2B08F7A70826](/claim/clm_2B08F7A70826.md) - 2025-07-09 | board_member | David Kirk | valid | [clm_04F204149CD3](/claim/clm_04F204149CD3.md) - 2025-07-09 | board_member | Amy Chang | valid | [clm_C3D404A8C99C](/claim/clm_C3D404A8C99C.md) - 2025-07-31 to 2025-10-31 | quarterly_research_and_development | 1,481,000,000 United States dollar | superseded | [clm_199ED226782E](/claim/clm_199ED226782E.md) - 2025-07-31 to 2025-10-31 | total_assets | 97,573,000,000 United States dollar | superseded | [clm_589F2A9CB9B2](/claim/clm_589F2A9CB9B2.md) - 2025-07-31 to 2025-10-31 | total_equity | 61,328,000,000 United States dollar | superseded | [clm_5EF7EB4D1FDF](/claim/clm_5EF7EB4D1FDF.md) - 2025-07-31 to 2025-10-31 | quarterly_operating_income | 2,332,000,000 United States dollar | superseded | [clm_5F7C0BAB5EE0](/claim/clm_5F7C0BAB5EE0.md) - 2025-07-31 to 2025-10-31 | cash_and_equivalents | 10,365,000,000 United States dollar | superseded | [clm_C569EE286979](/claim/clm_C569EE286979.md) - 2025-07-31 to 2025-10-31 | quarterly_net_income | 1,887,000,000 United States dollar | superseded | [clm_D9CDCB754D14](/claim/clm_D9CDCB754D14.md) - 2025-07-31 to 2025-10-31 | quarterly_revenue | 10,236,000,000 United States dollar | superseded | [clm_F2D054B06C62](/claim/clm_F2D054B06C62.md) - 2025-08-06 | model_release | Salesforce/moirai-2.0-R-small | valid | [clm_456A6C2E595D](/claim/clm_456A6C2E595D.md) - 2025-08-28 to 2025-11-28 | shares_outstanding | 952,000,000 shares | superseded | [clm_6DF429135B0A](/claim/clm_6DF429135B0A.md) - 2025-09-25 | model_release | Salesforce/GTA1-7B-2507 | valid | [clm_0BF93A1E3D54](/claim/clm_0BF93A1E3D54.md) - 2025-09-25 | model_release | Salesforce/CoDA-v0-Base | valid | [clm_22C574862B92](/claim/clm_22C574862B92.md) - 2025-09-25 | model_release | Salesforce/CoDA-v0-Instruct | valid | [clm_57D33AD82F03](/claim/clm_57D33AD82F03.md) - 2025-09-25 | model_release | Salesforce/GTA1-32B | valid | [clm_839A99366AB2](/claim/clm_839A99366AB2.md) - 2025-10-01 | model_release | Salesforce/GTA1-7B | valid | [clm_1C286F7D585A](/claim/clm_1C286F7D585A.md) - 2025-10-15 | model_release | Salesforce/FARE-20B | valid | [clm_E7F6D259BD80](/claim/clm_E7F6D259BD80.md) - 2025-10-21 | model_release | Salesforce/FARE-8B | valid | [clm_138FFB35B31C](/claim/clm_138FFB35B31C.md) - 2025-10-22 | model_release | Salesforce/Llama-Fin-8b | valid | [clm_E83DC35CFEC3](/claim/clm_E83DC35CFEC3.md) - 2025-10-30 | model_release | Salesforce/xRouter | valid | [clm_2963376AF5DC](/claim/clm_2963376AF5DC.md) - 2025-10-31 to 2026-04-30 | quarterly_research_and_development | 1,433,000,000 United States dollar | superseded | [clm_0E0D3C76474F](/claim/clm_0E0D3C76474F.md) - 2025-10-31 to 2026-01-31 | cash_and_equivalents | 8,978,000,000 United States dollar | superseded | [clm_19D0EEF16477](/claim/clm_19D0EEF16477.md) - 2025-10-31 to 2026-01-31 | total_assets | 95,144,000,000 United States dollar | superseded | [clm_75BF8030A837](/claim/clm_75BF8030A837.md) - 2025-10-31 to 2026-04-30 | quarterly_operating_income | 2,188,000,000 United States dollar | superseded | [clm_77EF8265E170](/claim/clm_77EF8265E170.md) - 2025-10-31 to 2026-04-30 | quarterly_net_income | 2,086,000,000 United States dollar | superseded | [clm_8F340F842DBC](/claim/clm_8F340F842DBC.md) - 2025-10-31 to 2026-01-31 | total_equity | 60,021,000,000 United States dollar | superseded | [clm_C89BD8AFBA27](/claim/clm_C89BD8AFBA27.md) - 2025-10-31 to 2026-04-30 | quarterly_revenue | 10,259,000,000 United States dollar | superseded | [clm_E8F851F4B3DF](/claim/clm_E8F851F4B3DF.md) - 2025-11-02 | model_release | Salesforce/BLIP3o-NEXT-GRPO-Geneval-3B | valid | [clm_075F164E5524](/claim/clm_075F164E5524.md) - 2025-11-02 | model_release | Salesforce/BLIP3o-NEXT-edit-VAE | valid | [clm_3C0A4843A6C1](/claim/clm_3C0A4843A6C1.md) - 2025-11-02 | model_release | Salesforce/BLIP3o-NEXT-Pretrain-3B | valid | [clm_569C3DA31A19](/claim/clm_569C3DA31A19.md) - 2025-11-02 | model_release | Salesforce/BLIP3o-NEXT-GRPO-TexT-3B | valid | [clm_6C3A6660EB7F](/claim/clm_6C3A6660EB7F.md) - 2025-11-04 | model_release | Salesforce/BLIP3o-NEXT-EDIT-ENSEMBLE-DATASETS | valid | [clm_A91F1E927446](/claim/clm_A91F1E927446.md) - 2025-11-04 | model_release | Salesforce/BLIP3o-NEXT-SFT-3B | valid | [clm_D9F2BA9B1FBD](/claim/clm_D9F2BA9B1FBD.md) - 2025-11-09 | model_release | Salesforce/UniDoc-Bench | valid | [clm_894EB4C8A4D5](/claim/clm_894EB4C8A4D5.md) - 2025-11-28 to 2026-02-25 | shares_outstanding | 937,000,000 shares | superseded | [clm_1189127176B0](/claim/clm_1189127176B0.md) - 2025-12-09 | model_release | Salesforce/FOFPred | valid | [clm_8A7FD23010E8](/claim/clm_8A7FD23010E8.md) - 2025-12-29 | model_release | Salesforce/moirai-agent | valid | [clm_700F0841FF21](/claim/clm_700F0841FF21.md) ## 2026 - 2026-01-31 to 2026-04-30 | cash_and_equivalents | 7,327,000,000 United States dollar | superseded | [clm_32E4B31711C7](/claim/clm_32E4B31711C7.md) - 2026-01-31 to 2026-04-30 | total_equity | 59,142,000,000 United States dollar | superseded | [clm_36BAFD56D9B3](/claim/clm_36BAFD56D9B3.md) - 2026-01-31 | net_income | 7,457,000,000 United States dollar | valid | [clm_45DDF45DF9E3](/claim/clm_45DDF45DF9E3.md) - 2026-01-31 | revenue | 41,525,000,000 United States dollar | valid | [clm_5202A262F5E0](/claim/clm_5202A262F5E0.md) - 2026-01-31 | research_and_development | 5,993,000,000 United States dollar | valid | [clm_61DFBCE17B94](/claim/clm_61DFBCE17B94.md) - 2026-01-31 to 2026-04-30 | total_assets | 112,305,000,000 United States dollar | superseded | [clm_7E88F6E3E5AF](/claim/clm_7E88F6E3E5AF.md) - 2026-01-31 | employees | 83,334 | valid | [clm_7F4E098369B3](/claim/clm_7F4E098369B3.md) - 2026-01-31 | operating_income | 8,331,000,000 United States dollar | valid | [clm_8159286A77F8](/claim/clm_8159286A77F8.md) - 2026-02-25 to 2026-05-21 | shares_outstanding | 923,000,000 shares | superseded | [clm_C11B392A842A](/claim/clm_C11B392A842A.md) - 2026-02-26 | model_release | Salesforce/GPA-GUI-Detector | valid | [clm_D91E3B1ED5FF](/claim/clm_D91E3B1ED5FF.md) - 2026-03-16 | model_release | Salesforce/ST-Evidence-3B | valid | [clm_89989B57377C](/claim/clm_89989B57377C.md) - 2026-03-16 | model_release | Salesforce/ST-Evidence-7B | valid | [clm_FA738180E262](/claim/clm_FA738180E262.md) - 2026-04-30 to 2026-07-31 | total_equity | 34,235,000,000 United States dollar | superseded | [clm_005501B3101A](/claim/clm_005501B3101A.md) - 2026-04-30 to 2026-07-31 | total_assets | 106,680,000,000 United States dollar | superseded | [clm_08929A031FD7](/claim/clm_08929A031FD7.md) - 2026-04-30 to 2026-07-31 | quarterly_research_and_development | 1,627,000,000 United States dollar | superseded | [clm_27CF2D062220](/claim/clm_27CF2D062220.md) - 2026-04-30 to 2026-07-31 | quarterly_revenue | 11,133,000,000 United States dollar | superseded | [clm_4005FF632E12](/claim/clm_4005FF632E12.md) - 2026-04-30 to 2026-07-31 | quarterly_net_income | 2,107,000,000 United States dollar | superseded | [clm_65668F53CE84](/claim/clm_65668F53CE84.md) - 2026-04-30 to 2026-07-31 | cash_and_equivalents | 8,935,000,000 United States dollar | superseded | [clm_6AFC739E7A9A](/claim/clm_6AFC739E7A9A.md) - 2026-04-30 to 2026-07-31 | quarterly_operating_income | 2,347,000,000 United States dollar | superseded | [clm_B915DF464B39](/claim/clm_B915DF464B39.md) - 2026-05-21 to 2026-08-20 | shares_outstanding | 819,000,000 shares | superseded | [clm_D2A341D0C144](/claim/clm_D2A341D0C144.md) - 2026-06-16 | model_release | Salesforce/RetailSim-GRPO-4B | valid | [clm_C1F1A8E947EA](/claim/clm_C1F1A8E947EA.md) - 2026-07-31 | total_equity | 38,378,000,000 United States dollar | valid | [clm_14A5A640138D](/claim/clm_14A5A640138D.md) - 2026-07-31 | quarterly_operating_income | 2,331,000,000 United States dollar | valid | [clm_2254E269D860](/claim/clm_2254E269D860.md) - 2026-07-31 | quarterly_research_and_development | 1,687,000,000 United States dollar | valid | [clm_59A0A22B7026](/claim/clm_59A0A22B7026.md) - 2026-07-31 | quarterly_net_income | 3,526,000,000 United States dollar | valid | [clm_9288569E8E22](/claim/clm_9288569E8E22.md) - 2026-07-31 | total_assets | 109,620,000,000 United States dollar | valid | [clm_A84CE9ED46A6](/claim/clm_A84CE9ED46A6.md) - 2026-07-31 | quarterly_revenue | 11,345,000,000 United States dollar | valid | [clm_BB854FEBB443](/claim/clm_BB854FEBB443.md) - 2026-07-31 | cash_and_equivalents | 8,310,000,000 United States dollar | valid | [clm_DC514CF738A7](/claim/clm_DC514CF738A7.md) - 2026-08-20 | shares_outstanding | 823,000,000 shares | valid | [clm_2D3DA8111E0E](/claim/clm_2D3DA8111E0E.md) - 2026-10-15 | customer | Tottenham Hotspur | valid | [clm_02F0763F9B39](/claim/clm_02F0763F9B39.md) - 2026-10-15 | customer | HM Revenue and Customs | valid | [clm_4E71456A7F63](/claim/clm_4E71456A7F63.md) - 2026-10-15 | partnership | UK higher and further education students | valid | [clm_A6308726095A](/claim/clm_A6308726095A.md) - 2026-10-19 | opened_office | Madrid EMEA South hub | valid | [clm_53E41714AB93](/claim/clm_53E41714AB93.md) - 2026-10-19 | investment | $1 billion in Spain | valid | [clm_DBD08614493C](/claim/clm_DBD08614493C.md) - 2026-10-20 | acquired | [Braze](/record/braze.md) | valid | [clm_AA3B44A25E87](/claim/clm_AA3B44A25E87.md) - 2026-10-27 | feature_added | Agent Evals | valid | [clm_B88AE15CA384](/claim/clm_B88AE15CA384.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.